Organ-limited amyloidosis

E4_AMYL_ORGAN

amyloidosis: A disorder characterized by the localized or diffuse accumulation of amyloid protein in various anatomic sites. It may be primary, due to clonal plasma cell proliferations; secondary, due to long standing infections, chronic inflammatory disorders, or malignancies; or familial. It may affect the nerves, skin, tongue, joints, heart, liver, spleen, kidneys and adrenal glands.

Suggest a new description

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519870
1. Apply sex-specific rule None	519870
2. Check conditions None	519870
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — E85.4 Cause of death: ICD-10 — E85.4 2 out of 7 registries used, show all original rules.	191
4. Check minimum number of events None	191
5. Include endpoints None	191
6. Filter based on genotype QC (FinnGen only)	187

Control definitions (FinnGen only)

Control exclude: E4_METABOLIA

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: E85
Name in latin: Amyloidosis in uno organo

NAME	E4_AMYL_ORGAN
CONTROL_EXCLUDE	E4_METABOLIA
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	E854
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	E854
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Organ-limited amyloidosis based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	1581	719	850
Only index persons	1221	545	676
Unadjusted period prevalence (%)
Whole population	0.02	0.02	0.02
Only index persons	0.02	0.02	0.03
Median age at first event (years)
Whole population	83.24	84.01	82.64
Only index persons	83.19	84.14	82.43

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	187	69	118
Unadjusted period prevalence (%)	0.04	0.02	0.05
Median age at first event (years)	78.02	72.46	81.27

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
191: Matched controls
1910

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

E85.4

ICD-10 Finland

Organ-limited amyloidosis

+∞

276.4

191

E85.9

ICD-10 Finland

Amyloidosis, unspecified

+∞

51.4

I43.1*E85.9

ICD-10 Finland

Cardiac amyloidosis

+∞

41.1

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

4.0

19.3

301

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

4.1

18.2

227

I50.9

ICD-10 Finland

Heart failure, unspecified

3.8

17.5

287

E85.89

ICD-10 Finland

Other amyloidosis

+∞

16.9

C03DA01

ATC

spironolactone; oral

4.4

16.7

146

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

5.8

16.4

I50.0

ICD-10 Finland

Congestive heart failure

4.4

15.8

136

GD1AA

NOMESCO Finland

Thorax X-ray examination

3.4

14.9

128

708

C03CA01

ATC

furosemide; systemic

3.2

13.9

117

629

WX892

NOMESCO Finland

Monitored bed care

4.9

13.0

N08.4*E85.9

ICD-10 Finland

Glomerular disorders in amyloidosis

+∞

12.6

E78.00

ICD-10 Finland

Familial hypercholesterolaemia

69.3

11.8

I43.1

ICD-10 Finland

Cardiomyopathy in metabolic diseases

+∞

11.6

FJA10

NOMESCO Finland

Transvenous biopsy of right ventricle

127.4

11.6

I61.1

ICD-10 Finland

Intracerebral haemorrhage in hemisphere, cortical

37.5

11.4

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

5.8

10.9

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

3.6

10.8

134

I68.0*E85.9

ICD-10 Finland

Cerebral amyloid angiopathy

+∞

10.5

I25.1

ICD-10 Finland

Atherosclerotic heart disease

2.8

10.2

368

E85.3

ICD-10 Finland

Secondary systemic amyloidosis

+∞

9.4

I61.0

ICD-10 Finland

Intracerebral haemorrhage in hemisphere, subcortical

13.4

9.0

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

2.8

9.0

245

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

4.6

8.2

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

2.6

8.1

306

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

4.8

8.1

I69.1

ICD-10 Finland

Sequelae of intracerebral haemorrhage

13.8

8.0

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.4

7.9

479

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

2.5

7.4

268

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

4.8

7.3

N08.4

ICD-10 Finland

Glomerular disorders in other endocrine, nutritional and metabolic diseases

+∞

7.3

C10AA01

ATC

simvastatin; oral

2.3

7.3

104

655

KA3AT

NOMESCO Finland

Biopsy of kidney with ultrasound guidance

31.3

7.2

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

2.6

7.2

243

207

Kela drug reimbursment

Chronic arrhythmias

2.5

7.1

272

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

8.0

7.0

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

9.2

6.7

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

2.4

6.6

309

TFJ02

NOMESCO Finland

Muscle biopsy of heart

72.2

6.5

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

2.7

6.4

173

I48

ICD-10 Finland

Atrial fibrillation and flutter

2.2

6.3

440

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

2.8

6.3

148

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

18.8

6.3

E85.0

ICD-10 Finland

Non-neuropathic heredofamilial amyloidosis

+∞

6.3

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.9

6.3

130

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

3.4

6.3

TFP20

NOMESCO Finland

Cardiodefibrillation

3.0

6.2

107

AA1AD

NOMESCO Finland

CT of head and brain

2.2

6.1

428

TPH04

NOMESCO Finland

Cathetrisation of vein

2.4

6.1

252

X59

ICD-10 Finland

Exposure to unspecified factor

2.6

6.1

177

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

4.0

6.1

TimeCodeWAS

↥

TODO / Current known limitations:

Only showing the top 300 codes, because showing all (sometimes 20k) makes the page too slow.
Legend / how to read the glyphs.
Show details (e.g. Fisher or Chi-square test, LR+, etc.) when clicking on a row.
Explanation on the underlying data / how the TimeCodeWAS is done (e.g. matched cases / controls, eligibility).
Download CSV.
No filters and sorters.
Limited amount of endpoints (~400) having TimeCodeWAS data.
Cross-links to Risteys lab test pages for lab test codes.

OMOP concept

ln(OR)

%cases with code / %controls with code

2×2 table

Congestive heart failure
I50.0 [45567179]

1.8e+00

2.8e+00

3.1e+00

—

cases:13.09%

controls:2.36%

cases:14.14%

controls:0.99%

cases:7.33%

controls:0.37%

—

166

1865

164

1891

177

1903

—

C reactive protein [Mass/volume] in Serum or Plasma
1988-5 [3020460]

4.6e-01

1.2e+00

2.5e+00

3.7e+00

—

cases:60.73%

controls:49.37%

cases:59.69%

controls:31.88%

cases:46.07%

controls:6.44%

cases:13.09%

controls:0.37%

—

116

943

967

114

609

1301

123

103

1787

166

1903

—

Heart failure, unspecified
I50.9 [45576879]

1.6e+00

2.3e+00

3.4e+00

—

cases:19.90%

controls:4.82%

cases:25.65%

controls:3.30%

cases:14.14%

controls:0.52%

—

153

1818

142

1847

164

1900

—

Supine thorax X-ray examination
GD1QA [2001303648]

1.5e+00

1.9e+00

3.8e+00

—

cases:19.37%

controls:4.87%

cases:13.09%

controls:2.20%

cases:12.57%

controls:0.31%

—

154

1817

166

1868

167

1904

—

Sodium [Moles/volume] in Serum or Plasma
2951-2 [3019550]

1.9e-01

7.1e-01

2.3e+00

3.8e+00

—

cases:64.92%

controls:60.37%

cases:65.97%

controls:48.85%

cases:49.21%

controls:8.85%

cases:13.61%

controls:0.37%

—

124

1153

757

126

933

977

169

1741

165

1903

—

Potassium [Moles/volume] in Serum or Plasma
2823-3 [3023103]

2.1e-01

6.8e-01

2.3e+00

3.8e+00

—

cases:65.45%

controls:60.52%

cases:65.97%

controls:49.53%

cases:49.21%

controls:9.21%

cases:13.61%

controls:0.37%

—

125

1156

754

126

946

964

176

1734

165

1903

—

pH of Capillary blood
2745-8 [3009343]

1.3e+00

2.3e+00

3.0e+00

—

cases:7.33%

controls:2.09%

cases:8.90%

controls:0.94%

cases:5.24%

controls:0.26%

—

177

1870

174

1892

181

1905

—

Carbon dioxide [Partial pressure] in Capillary blood
2020-6 [3023024]

1.3e+00

2.3e+00

3.0e+00

—

cases:7.33%

controls:2.09%

cases:8.90%

controls:0.99%

cases:5.24%

controls:0.26%

—

177

1870

174

1891

181

1905

—

INR in Blood by Coagulation assay
34714-6 [3032080]

8.6e-01

1.5e+00

1.7e+00

2.5e+00

—

cases:43.46%

controls:24.55%

cases:40.84%

controls:13.87%

cases:22.51%

controls:5.03%

cases:3.66%

controls:0.31%

—

469

108

1441

265

113

1645

148

1814

184

1904

—

Phosphate [Moles/volume] in Serum or Plasma
14879-1 [3003458]

1.3e+00

2.2e+00

2.9e+00

—

cases:15.18%

controls:4.50%

cases:17.80%

controls:2.30%

cases:7.33%

controls:0.42%

—

162

1824

157

1866

177

1902

—

Left ventricular failure
I50.1 [45543181]

1.6e+00

2.3e+00

2.5e+00

—

cases:4.71%

controls:0.99%

cases:5.76%

controls:0.63%

cases:3.14%

controls:0.26%

—

182

1891

180

1898

185

1905

—

Creatinine [Moles/volume] in Serum or Plasma
14682-9 [3020564]

9.5e-02

5.9e-01

2.1e+00

3.7e+00

—

cases:64.92%

controls:62.72%

cases:67.02%

controls:53.09%

cases:49.21%

controls:10.58%

cases:14.14%

controls:0.42%

—

124

1198

712

128

1014

896

202

1708

164

1902

—

Chronic kidney disease, unspecified
N18.9 [45553438]

1.7e+00

2.3e+00

—

cases:8.90%

controls:1.68%

cases:8.90%

controls:0.99%

cases:3.14%

controls:0.31%

—

174

1878

174

1891

185

1904

—

Hematology
82 [38004501]

1.8e+00

2.3e+00

—

cases:10.99%

controls:2.09%

cases:14.14%

controls:1.57%

cases:5.24%

controls:0.58%

—

170

1870

164

1880

181

1899

—

Thorax X-ray examination
GD1AA [2001303617]

1.3e+00

1.9e+00

3.0e+00

—

cases:40.84%

controls:16.02%

cases:30.37%

controls:6.07%

cases:12.57%

controls:0.73%

—

306

113

1604

116

133

1794

167

1896

—

Pneumonia, unspecified
J18.9 [45601123]

1.1e+00

1.6e+00

3.3e+00

1.0e+50

—

cases:17.80%

controls:6.65%

cases:12.04%

controls:2.77%

cases:6.81%

controls:0.26%

cases:7.85%

controls:0.00%

—

127

157

1783

168

1857

178

1905

176

1910

—

Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M
62238-1 [40764999]

2.9e-01

5.4e-01

2.0e+00

3.5e+00

—

cases:52.36%

controls:45.24%

cases:52.36%

controls:39.01%

cases:37.17%

controls:7.64%

cases:9.42%

controls:0.31%

—

100

864

1046

100

745

1165

146

120

1764

173

1904

—

Hematocrit [Volume Fraction] of Blood by calculation
20570-8 [3009542]

1.7e-01

5.6e-01

2.0e+00

3.3e+00

—

cases:68.06%

controls:64.19%

cases:67.02%

controls:53.77%

cases:48.69%

controls:11.36%

cases:14.14%

controls:0.58%

—

130

1226

684

128

1027

883

217

1693

164

1899

—

Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
34487-9 [3044938]

1.2e+00

1.4e+00

3.3e+00

—

cases:13.09%

controls:4.35%

cases:9.95%

controls:2.57%

cases:10.99%

controls:0.47%

—

166

1827

172

1861

170

1901

—

MCH [Entitic mass]
28539-5 [3035941]

1.8e-01

5.6e-01

2.0e+00

3.3e+00

—

cases:68.06%

controls:64.14%

cases:67.02%

controls:53.77%

cases:48.69%

controls:11.36%

cases:13.61%

controls:0.58%

—

130

1225

685

128

1027

883

217

1693

165

1899

—

Leukocytes [#/volume] in Blood
26464-8 [3010813]

1.7e-01

5.6e-01

2.0e+00

3.3e+00

—

cases:68.06%

controls:64.24%

cases:67.02%

controls:53.77%

cases:48.69%

controls:11.36%

cases:13.61%

controls:0.58%

—

130

1227

683

128

1027

883

217

1693

165

1899

—

Erythrocytes [#/volume] in Blood
26453-1 [3026361]

1.7e-01

5.5e-01

2.0e+00

3.3e+00

—

cases:68.06%

controls:64.19%

cases:67.02%

controls:53.87%

cases:48.69%

controls:11.36%

cases:13.61%

controls:0.58%

—

130

1226

684

128

1029

881

217

1693

165

1899

—

MCV [Entitic mean volume] in Red Blood Cells
30428-7 [3024731]

1.7e-01

5.5e-01

2.0e+00

3.3e+00

—

cases:68.06%

controls:64.19%

cases:67.02%

controls:53.87%

cases:48.69%

controls:11.36%

cases:13.61%

controls:0.58%

—

130

1226

684

128

1029

881

217

1693

165

1899

—

Platelets [#/volume] in Blood
26515-7 [3007461]

1.8e-01

5.5e-01

2.0e+00

3.3e+00

—

cases:68.06%

controls:63.98%

cases:67.02%

controls:53.87%

cases:48.69%

controls:11.36%

cases:13.61%

controls:0.58%

—

130

1222

688

128

1029

881

217

1693

165

1899

—

Hemoglobin [Mass/volume] in Blood
718-7 [3000963]

1.7e-01

5.5e-01

2.0e+00

3.3e+00

—

cases:68.06%

controls:64.24%

cases:67.02%

controls:53.87%

cases:48.69%

controls:11.41%

cases:13.61%

controls:0.58%

—

130

1227

683

128

1029

881

218

1692

165

1899

—

Blood type and Crossmatch panel - Blood
34531-4 [3044640]

9.0e-01

1.4e+00

3.5e+00

—

cases:25.13%

controls:12.04%

cases:17.28%

controls:4.97%

cases:8.38%

controls:0.26%

—

230

143

1680

158

1815

175

1905

—

Prothrombin time (PT) actual/Normal
5894-1 [3033658]

1.1e+00

1.6e+00

3.1e+00

—

cases:21.47%

controls:8.64%

cases:18.32%

controls:4.29%

cases:9.95%

controls:0.47%

—

165

150

1745

156

1828

172

1901

—

Emergency Room and Inpatient Visit
ERIP [262]

1.0e+00

1.6e+00

3.2e+00

—

cases:26.18%

controls:11.57%

cases:30.89%

controls:8.27%

cases:23.04%

controls:1.20%

—

221

141

1689

158

132

1752

147

1887

—

Troponin T.cardiac [Mass/volume] in Serum or Plasma
6598-7 [3019800]

8.6e-01

1.6e+00

3.4e+00

—

cases:33.51%

controls:17.64%

cases:32.46%

controls:8.95%

cases:20.42%

controls:0.89%

—

337

127

1573

171

129

1739

152

1893

—

Palliative care
Z51.5 [45547323]

2.1e+00

2.6e+00

3.1e+00

—

cases:2.62%

controls:0.31%

cases:6.81%

controls:0.52%

cases:6.81%

controls:0.31%

—

186

1904

178

1900

178

1904

—

Emergency Room Visit
ER [9203]

9.7e-01

1.7e+00

3.1e+00

1.0e+50

—

cases:65.45%

controls:41.68%

cases:43.46%

controls:12.57%

cases:27.23%

controls:1.68%

cases:5.76%

controls:0.00%

—

125

796

1114

240

108

1670

139

1878

180

1910

—

Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
33762-6 [3029187]

1.2e+00

1.7e+00

2.8e+00

—

cases:34.03%

controls:13.09%

cases:35.08%

controls:8.74%

cases:17.28%

controls:1.31%

—

250

126

1660

167

124

1743

158

1885

—

CBC panel - Blood by Automated count
58410-2 [40761511]

2.1e-01

6.6e-01

1.9e+00

3.1e+00

—

cases:60.73%

controls:55.65%

cases:52.36%

controls:36.28%

cases:31.94%

controls:6.54%

cases:5.76%

controls:0.26%

—

116

1063

847

100

693

1217

125

130

1785

180

1905

—

Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
14804-9 [3022250]

1.3e+00

1.9e+00

2.6e+00

—

cases:15.18%

controls:4.87%

cases:13.09%

controls:2.30%

cases:4.71%

controls:0.37%

—

162

1817

166

1866

182

1903

—

Kappa light chains/Lambda light chains [Mass Ratio] in Serum
15189-4 [3007778]

2.6e+00

3.1e+00

—

cases:16.23%

controls:1.36%

cases:10.99%

controls:0.58%

—

160

1884

170

1899

—

Kappa light chains.free [Mass/volume] in Serum
36916-5 [3034860]

2.6e+00

3.1e+00

—

cases:16.23%

controls:1.36%

cases:10.99%

controls:0.58%

—

160

1884

170

1899

—

Lambda light chains.free [Mass/volume] in Serum or Plasma
33944-0 [3047169]

2.6e+00

3.1e+00

—

cases:16.23%

controls:1.36%

cases:10.99%

controls:0.58%

—

160

1884

170

1899

—

Immunoglobulin light chains.free panel - Serum
57778-3 [40760888]

2.6e+00

2.9e+00

—

cases:14.14%

controls:1.20%

cases:7.85%

controls:0.47%

—

164

1887

176

1901

—

Calcium.ionized [Moles/volume] in Serum or Plasma
1995-0 [3021347]

8.4e-01

1.5e+00

3.2e+00

1.0e+50

—

cases:35.60%

controls:19.32%

cases:31.94%

controls:9.84%

cases:18.85%

controls:0.94%

cases:2.62%

controls:0.00%

—

369

123

1541

188

130

1722

155

1892

186

1910

—

Bacteria identified in Blood by Culture
600-7 [3023368]

7.9e-01

1.5e+00

3.2e+00

—

cases:21.99%

controls:11.36%

cases:19.90%

controls:5.50%

cases:14.66%

controls:0.68%

—

217

149

1693

105

153

1805

163

1897

—

Inpatient Hospital
21 [8717]

9.1e-01

1.4e+00

3.0e+00

—

cases:59.16%

controls:36.86%

cases:31.94%

controls:10.05%

cases:19.90%

controls:1.26%

—

113

704

1206

192

130

1718

153

1886

—

Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
19072-8 [3016431]

8.8e-01

1.5e+00

3.0e+00

1.0e+50

—

cases:38.74%

controls:20.84%

cases:35.60%

controls:11.36%

cases:20.42%

controls:1.31%

cases:2.62%

controls:0.00%

—

398

117

1512

217

123

1693

152

1885

186

1910

—

oxycodone; oral, parenteral
N02AA05 [21604260]

1.5e+00

1.8e+00

2.0e+00

—

cases:9.42%

controls:2.36%

cases:10.47%

controls:1.88%

cases:3.66%

controls:0.52%

—

173

1865

171

1874

184

1900

—

Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
2157-6 [3007220]

8.3e-01

1.3e+00

3.1e+00

—

cases:21.47%

controls:10.63%

cases:13.09%

controls:4.14%

cases:9.95%

controls:0.47%

—

203

150

1707

166

1831

172

1901

—

Albumin [Mass/volume] in Serum or Plasma
1751-7 [3024561]

9.2e-01

1.6e+00

2.7e+00

—

cases:35.08%

controls:17.70%

cases:34.03%

controls:9.32%

cases:14.66%

controls:1.15%

—

338

124

1572

178

126

1732

163

1888

—

alfacalcidol; oral, parenteral
A11CC03 [21600818]

2.6e+00

2.5e+00

—

cases:4.19%

controls:0.31%

cases:3.14%

controls:0.26%

—

183

1904

185

1905

—

Outpatient Hospital
22 [8756]

6.7e-01

1.6e+00

2.9e+00

—

cases:47.12%

controls:31.31%

cases:24.08%

controls:6.02%

cases:13.61%

controls:0.89%

—

598

101

1312

115

145

1795

165

1893

—

Outpatient Visit
OP [9202]

7.9e-01

8.3e-01

8.2e-01

3.5e+00

—

cases:93.72%

controls:87.12%

cases:84.29%

controls:70.10%

cases:27.23%

controls:14.19%

cases:14.66%

controls:0.52%

—

179

1664

246

161

1339

571

271

139

1639

163

1900

—

General Practice
1 [38004446]

8.0e-01

1.6e+00

2.7e+00

—

cases:42.93%

controls:25.24%

cases:38.22%

controls:11.47%

cases:23.56%

controls:1.94%

—

482

109

1428

219

118

1691

146

1873

—

Dyspnoea
R06.0 [45558449]

9.2e-01

1.7e+00

2.5e+00

—

cases:14.14%

controls:6.18%

cases:9.42%

controls:1.94%

cases:3.14%

controls:0.26%

—

118

164

1792

173

1873

185

1905

—

IgM [Mass/volume] in Serum or Plasma
2472-9 [3028026]

2.4e+00

2.7e+00

—

cases:9.95%

controls:0.99%

cases:7.85%

controls:0.58%

—

172

1891

176

1899

—

Internal Medicine
11 [38004456]

1.1e+00

1.3e+00

2.7e+00

—

cases:52.88%

controls:27.59%

cases:30.89%

controls:11.26%

cases:17.80%

controls:1.47%

—

101

527

1383

215

132

1695

157

1882

—

Glucose [Moles/volume] in Serum or Plasma
14749-6 [3013826]

5.7e-01

1.4e+00

3.0e+00

1.0e+50

—

cases:36.65%

controls:24.66%

cases:35.60%

controls:11.94%

cases:24.08%

controls:1.52%

cases:4.71%

controls:0.00%

—

471

121

1439

228

123

1682

145

1881

182

1910

—

Bilirubin.total [Moles/volume] in Serum or Plasma
14631-6 [3006140]

7.2e-01

1.5e+00

2.8e+00

1.0e+50

—

cases:33.51%

controls:19.69%

cases:34.03%

controls:10.37%

cases:19.90%

controls:1.52%

cases:2.62%

controls:0.00%

—

376

127

1534

198

126

1712

153

1881

186

1910

—

Amylase [Enzymatic activity/volume] in Serum or Plasma
1798-8 [3016771]

6.8e-01

1.5e+00

2.8e+00

—

cases:19.37%

controls:10.84%

cases:15.71%

controls:4.03%

cases:7.85%

controls:0.52%

—

207

154

1703

161

1833

176

1900

—

MCHC [Entitic Mass/volume] in Red Blood Cells
28540-3 [3003338]

-1.5e-01

1.9e-01

1.5e+00

3.4e+00

—

cases:40.31%

controls:44.08%

cases:38.74%

controls:34.45%

cases:25.65%

controls:6.96%

cases:7.33%

controls:0.26%

—

842

114

1068

658

117

1252

133

142

1777

177

1905

—

pH of Serum or Plasma
2753-2 [3018418]

8.1e-01

1.3e+00

2.8e+00

—

cases:21.99%

controls:11.10%

cases:18.85%

controls:6.02%

cases:8.90%

controls:0.58%

—

212

149

1698

115

155

1795

174

1899

—

Nephrology
39 [38004479]

2.2e+00

2.7e+00

—

cases:10.99%

controls:1.31%

cases:11.52%

controls:0.89%

—

170

1885

169

1893

—

Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
95941-1 [36031861]

—

1.7e+00

3.1e+00

—

cases:4.19%

controls:0.79%

cases:7.85%

controls:0.37%

—

183

1895

176

1903

—

Differential panel, method unspecified - Blood
69738-3 [42870588]

1.2e+00

1.5e+00

2.2e+00

—

cases:29.32%

controls:11.57%

cases:22.51%

controls:6.34%

cases:8.90%

controls:1.10%

—

221

135

1689

121

148

1789

174

1889

—

Inpatient Visit
IP [9201]

6.7e-01

1.5e+00

2.6e+00

—

cases:19.37%

controls:10.94%

cases:21.47%

controls:5.76%

cases:9.95%

controls:0.84%

—

209

154

1701

110

150

1800

172

1894

—

Emergency Medicine
93 [38004510]

7.9e-01

1.3e+00

2.6e+00

—

cases:41.36%

controls:24.19%

cases:38.74%

controls:14.71%

cases:25.65%

controls:2.41%

—

462

112

1448

281

117

1629

142

1864

—

Laboratory Visit
OMOP4822461 [32036]

5.8e-02

4.2e-01

1.6e+00

3.0e+00

—

cases:68.59%

controls:67.33%

cases:70.68%

controls:61.41%

cases:56.02%

controls:20.99%

cases:19.90%

controls:1.20%

—

131

1286

624

135

1173

737

107

401

1509

153

1887

—

Bacteria [Presence] in Urine
87829-8 [36304419]

7.1e-01

1.3e+00

2.5e+00

—

cases:17.80%

controls:9.58%

cases:17.80%

controls:5.60%

cases:6.81%

controls:0.58%

—

183

157

1727

107

157

1803

178

1899

—

Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
30248-9 [3015399]

8.6e-01

1.3e+00

2.3e+00

—

cases:22.51%

controls:10.99%

cases:19.90%

controls:6.13%

cases:3.66%

controls:0.37%

—

210

148

1700

117

153

1793

184

1903

—

Monocytes/Leukocytes in Blood
26485-3 [3019069]

1.1e+00

1.5e+00

1.9e+00

—

cases:36.13%

controls:16.39%

cases:31.41%

controls:9.01%

cases:9.95%

controls:1.57%

—

313

122

1597

172

131

1738

172

1880

—

CBC W Ordered Manual Differential panel - Blood
57782-5 [40760892]

1.0e+00

1.2e+00

2.3e+00

—

cases:16.23%

controls:6.44%

cases:10.47%

controls:3.56%

cases:3.14%

controls:0.31%

—

123

160

1787

171

1842

185

1904

—

Cardiology
6 [38004451]

9.6e-01

1.3e+00

2.3e+00

—

cases:39.79%

controls:20.16%

cases:28.80%

controls:10.31%

cases:11.52%

controls:1.31%

—

385

115

1525

197

136

1713

169

1885

—

Monocytes [#/volume] in Blood
26484-6 [3001604]

1.2e+00

1.4e+00

1.9e+00

1.0e+50

—

cases:39.27%

controls:16.86%

cases:29.84%

controls:9.21%

cases:8.90%

controls:1.47%

cases:2.62%

controls:0.00%

—

322

116

1588

176

134

1734

174

1882

186

1910

—

Basophils/Leukocytes in Blood
30180-4 [3022096]

1.1e+00

1.5e+00

1.9e+00

—

cases:36.13%

controls:16.34%

cases:30.89%

controls:9.01%

cases:9.95%

controls:1.62%

—

312

122

1598

172

132

1738

172

1879

—

Lymphocytes/Leukocytes in Blood
26478-8 [3002030]

1.1e+00

1.4e+00

2.0e+00

—

cases:36.13%

controls:16.49%

cases:30.37%

controls:9.37%

cases:10.47%

controls:1.62%

—

315

122

1595

179

133

1731

171

1879

—

Eosinophils/Leukocytes in Blood
26450-7 [3006504]

1.1e+00

1.5e+00

1.9e+00

—

cases:36.13%

controls:16.44%

cases:30.89%

controls:8.95%

cases:9.95%

controls:1.68%

—

314

122

1596

171

132

1739

172

1878

—

Basophils [#/volume] in Blood
26444-0 [3006315]

1.2e+00

1.4e+00

1.8e+00

1.0e+50

—

cases:39.79%

controls:16.96%

cases:29.32%

controls:9.16%

cases:8.90%

controls:1.52%

cases:2.62%

controls:0.00%

—

324

115

1586

175

135

1735

174

1881

186

1910

—

Lymphocytes [#/volume] in Blood
26474-7 [3019198]

1.1e+00

1.4e+00

1.9e+00

—

cases:39.79%

controls:17.49%

cases:29.84%

controls:9.42%

cases:9.42%

controls:1.57%

—

334

115

1576

180

134

1730

173

1880

—

Eosinophils [#/volume] in Blood
26449-9 [3013115]

1.1e+00

1.4e+00

1.8e+00

1.0e+50

—

cases:39.79%

controls:17.43%

cases:30.37%

controls:9.63%

cases:9.42%

controls:1.62%

cases:2.62%

controls:0.00%

—

333

115

1577

184

133

1726

173

1879

186

1910

—

Blood group antibody screen [Presence] in Serum or Plasma
890-4 [3001079]

5.9e-01

1.5e+00

2.9e+00

—

cases:26.18%

controls:16.44%

cases:23.56%

controls:6.44%

cases:9.95%

controls:0.63%

—

314

141

1596

123

146

1787

172

1898

—

Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
51435-6 [3029713]

2.0e+00

2.4e+00

—

cases:9.42%

controls:1.41%

cases:6.28%

controls:0.63%

—

173

1883

179

1898

—

Fall on same level from slipping, tripping and stumbling
W01 [45756243]

4.7e-01

1.6e+00

2.8e+00

1.0e+50

—

cases:13.09%

controls:8.59%

cases:13.61%

controls:3.19%

cases:8.38%

controls:0.58%

cases:4.71%

controls:0.00%

—

164

166

1746

165

1849

175

1899

182

1910

—

Neutrophils [#/volume] in Blood by Automated count
751-8 [3013650]

9.7e-01

1.3e+00

2.0e+00

1.0e+50

—

cases:40.84%

controls:20.68%

cases:31.41%

controls:11.20%

cases:13.61%

controls:1.99%

cases:3.66%

controls:0.00%

—

395

113

1515

214

131

1696

165

1872

184

1910

—

Protein electrophoresis panel - Serum or Plasma
24351-9 [3004588]

2.0e+00

2.3e+00

—

cases:17.80%

controls:2.88%

cases:10.99%

controls:1.20%

—

157

1855

170

1887

—

Leukocytes [#/volume] in Urine
30405-5 [3018095]

6.6e-01

1.2e+00

2.4e+00

—

cases:21.47%

controls:12.41%

cases:21.47%

controls:7.64%

cases:8.90%

controls:0.84%

—

237

150

1673

146

150

1764

174

1894

—

pH of Specimen
17433-4 [3019225]

8.4e-01

1.2e+00

3.1e+00

—

cases:10.99%

controls:5.08%

cases:9.42%

controls:2.93%

cases:6.28%

controls:0.31%

—

170

1813

173

1854

179

1904

—

Urinalysis microscopic panel [#/volume] - Urine by Automated count
50554-5 [3029287]

6.8e-01

1.2e+00

2.4e+00

—

cases:24.61%

controls:14.14%

cases:21.99%

controls:7.80%

cases:8.38%

controls:0.84%

—

270

144

1640

149

1761

175

1894

—

Pure hypercholesterolaemia
E78.01 [2000501514]

1.6e+00

2.6e+00

—

cases:9.95%

controls:2.15%

cases:6.28%

controls:0.47%

—

172

1869

179

1901

—

Neutrophils/Leukocytes in Blood
26511-6 [3018010]

1.0e+00

1.5e+00

1.7e+00

—

cases:35.08%

controls:15.92%

cases:30.37%

controls:8.80%

cases:7.85%

controls:1.57%

—

304

124

1606

168

133

1742

176

1880

—

Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
50797-0 [3029379]

2.1e+00

—

cases:7.85%

controls:0.99%

cases:3.66%

controls:0.47%

—

176

1891

184

1901

—

furosemide; oral, parenteral
C03CA01 [21601518]

1.4e+00

1.7e+00

1.1e+00

—

cases:42.41%

controls:15.55%

cases:46.60%

controls:13.93%

cases:14.66%

controls:5.29%

—

297

110

1613

266

102

1644

101

163

1809

—

Joint ultrasound examination not elsewhere classified
NK4XE [2001308469]

2.0e+00

2.2e+00

—

cases:6.28%

controls:0.94%

cases:3.14%

controls:0.37%

—

179

1892

185

1903

—

Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
50796-2 [3029338]

2.0e+00

2.1e+00

—

cases:7.85%

controls:1.10%

cases:3.66%

controls:0.47%

—

176

1889

184

1901

—

IgG [Mass/volume] in Serum or Plasma
2465-3 [3005719]

2.1e+00

2.0e+00

—

cases:11.52%

controls:1.57%

cases:8.38%

controls:1.20%

—

169

1880

175

1887

—

Protein [Mass/volume] in Serum or Plasma
2885-2 [3020630]

1.8e+00

2.3e+00

—

cases:18.32%

controls:3.61%

cases:13.09%

controls:1.47%

—

156

1841

166

1882

—

Bacteria [#/volume] in Urine by Automated count
51480-2 [3031040]

5.5e-01

1.0e+00

2.5e+00

—

cases:42.41%

controls:29.90%

cases:35.60%

controls:16.23%

cases:19.37%

controls:1.94%

—

571

110

1339

310

123

1600

154

1873

—

EKG study
11524-6 [3013512]

6.9e-01

8.3e-01

2.6e+00

—

cases:27.23%

controls:15.76%

cases:17.28%

controls:8.32%

cases:11.52%

controls:0.99%

—

301

139

1609

159

158

1751

169

1891

—

Atrial fibrillation and flutter
I48 [45596206]

9.9e-01

9.6e-01

2.1e+00

—

cases:35.60%

controls:17.02%

cases:19.90%

controls:8.69%

cases:10.47%

controls:1.47%

—

325

123

1585

166

153

1744

171

1882

—

Immunohistochemistry procedure
117617002 [4035726]

1.7e+00

2.2e+00

—

cases:11.52%

controls:2.30%

cases:7.85%

controls:0.89%

—

169

1866

176

1893

—

Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
35559-4 [3035797]

2.0e+00

—

cases:8.38%

controls:1.26%

cases:3.66%

controls:0.52%

—

175

1886

184

1900

—

Atherosclerotic heart disease
I25.1 [45596196]

5.4e-01

9.7e-01

3.0e+00

—

cases:16.23%

controls:10.16%

cases:13.61%

controls:5.65%

cases:10.99%

controls:0.63%

—

194

160

1716

108

165

1802

170

1898

—

Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
40982-1 [3038288]

1.1e+00

2.8e+00

—

cases:7.85%

controls:2.72%

cases:4.71%

controls:1.62%

cases:5.76%

controls:0.37%

—

176

1858

182

1879

180

1903

—

Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
2865-4 [3015322]

1.9e+00

2.0e+00

—

cases:9.42%

controls:1.52%

cases:4.71%

controls:0.68%

—

173

1881

182

1897

—

Troponin I.cardiac [Mass/volume] in Serum or Plasma
10839-9 [3021337]

7.2e-01

1.2e+00

2.7e+00

—

cases:13.09%

controls:6.81%

cases:13.61%

controls:4.50%

cases:5.76%

controls:0.42%

—

130

166

1780

165

1824

180

1902

—

Treatment of chronic ulcer or burn
SPAT1148 [2001700249]

4.8e-01

1.4e+00

2.5e+00

—

cases:8.38%

controls:5.34%

cases:7.33%

controls:1.94%

cases:3.66%

controls:0.31%

—

102

175

1808

177

1873

184

1904

—

Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
32731-2 [3043747]

1.9e+00

2.0e+00

—

cases:9.95%

controls:1.62%

cases:4.71%

controls:0.68%

—

172

1879

182

1897

—

Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
32730-4 [3043723]

1.9e+00

2.0e+00

—

cases:9.95%

controls:1.62%

cases:4.71%

controls:0.68%

—

172

1879

182

1897

—

Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
2874-6 [3023465]

1.9e+00

2.0e+00

—

cases:9.95%

controls:1.62%

cases:4.71%

controls:0.68%

—

172

1879

182

1897

—

Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
2868-8 [3005229]

1.9e+00

2.0e+00

—

cases:9.95%

controls:1.62%

cases:4.71%

controls:0.68%

—

172

1879

182

1897

—

Neurology
13 [38004458]

5.5e-01

1.0e+00

2.8e+00

—

cases:22.51%

controls:14.35%

cases:13.09%

controls:5.13%

cases:12.04%

controls:0.79%

—

274

148

1636

166

1812

168

1895

—

SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
94500-6 [706163]

4.1e-01

1.2e+00

2.7e+00

—

cases:14.66%

controls:10.26%

cases:17.80%

controls:6.34%

cases:13.09%

controls:0.99%

—

196

163

1714

121

157

1789

166

1891

—

Urea [Moles/volume] in Serum or Plasma
22664-7 [3020779]

1.5e+00

2.3e+00

—

cases:12.57%

controls:2.98%

cases:13.61%

controls:1.52%

—

167

1853

165

1881

—

Pulmonary Disease
29 [38004472]

7.1e-01

1.1e+00

2.0e+00

1.0e+50

—

cases:23.04%

controls:12.83%

cases:18.85%

controls:7.12%

cases:4.71%

controls:0.68%

cases:4.71%

controls:0.00%

—

245

147

1665

136

155

1774

182

1897

182

1910

—

Ferritin [Mass/volume] in Serum or Plasma
2276-4 [3001122]

8.4e-01

1.3e+00

1.6e+00

—

cases:26.18%

controls:13.30%

cases:25.13%

controls:8.06%

cases:4.71%

controls:0.99%

—

254

141

1656

154

143

1756

182

1891

—

IgA [Mass/volume] in Serum or Plasma
2458-8 [3007164]

1.6e+00

2.2e+00

—

cases:14.14%

controls:3.25%

cases:10.47%

controls:1.31%

—

164

1848

171

1885

—

Monitored bed care
WX892 [2001310850]

1.3e+00

2.5e+00

1.0e+50

—

cases:6.28%

controls:1.83%

cases:4.19%

controls:0.37%

cases:3.66%

controls:0.00%

—

179

1875

183

1903

184

1910

—

Epithelial cells.non-squamous [#/volume] in Urine by Automated count
51485-1 [3030306]

3.8e-01

1.0e+00

2.7e+00

—

cases:7.85%

controls:5.50%

cases:10.47%

controls:4.03%

cases:5.24%

controls:0.37%

—

105

176

1805

171

1833

181

1903

—

Epithelial cells.squamous [#/volume] in Urine by Automated count
51486-9 [3029879]

4.2e-01

1.0e+00

2.7e+00

—

cases:8.38%

controls:5.65%

cases:9.42%

controls:3.66%

cases:5.24%

controls:0.37%

—

108

175

1802

173

1840

181

1903

—

Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
72720-6 [43055554]

1.3e+00

2.4e+00

—

cases:7.33%

controls:2.04%

cases:7.85%

controls:0.79%

—

177

1871

176

1895

—

aPTT in Platelet poor plasma by Coagulation assay
14979-9 [3018677]

1.1e+00

2.6e+00

—

cases:15.18%

controls:5.45%

cases:15.71%

controls:1.41%

—

104

162

1806

161

1883

—

Abnormal findings on diagnostic imaging of lung
R91 [45548995]

1.2e+00

2.4e+00

—

cases:6.28%

controls:1.88%

cases:7.33%

controls:0.68%

—

179

1874

177

1897

—

Casts [#/volume] in Urine by Automated count
51483-6 [3030467]

6.6e-01

1.3e+00

2.4e+00

—

cases:18.32%

controls:10.37%

cases:18.85%

controls:5.92%

cases:6.81%

controls:0.68%

—

198

156

1712

113

155

1797

178

1897

—

spironolactone; oral
C03DA01 [21601534]

1.7e+00

2.0e+00

1.1e+00

—

cases:15.18%

controls:3.14%

cases:17.80%

controls:2.98%

cases:3.66%

controls:1.20%

—

162

1850

157

1853

184

1887

—

Chronic atrial fibrillation
I48.2 [45591467]

1.8e+00

1.9e+00

—

cases:3.66%

controls:0.63%

cases:4.19%

controls:0.68%

—

184

1898

183

1897

—

Myelocytes/Leukocytes in Blood
26498-6 [3017181]

1.3e+00

1.2e+00

2.3e+00

—

cases:8.38%

controls:2.41%

cases:5.76%

controls:1.83%

cases:3.14%

controls:0.31%

—

175

1864

180

1875

185

1904

—

Haptoglobin [Mass/volume] in Serum or Plasma
4542-7 [3012336]

1.6e+00

2.0e+00

—

cases:8.90%

controls:1.94%

cases:5.24%

controls:0.73%

—

174

1873

181

1896

—

Abdominal ultrasound examination
JN3AE [2001305555]

1.4e+00

2.2e+00

—

cases:9.42%

controls:2.41%

cases:5.24%

controls:0.63%

—

173

1864

181

1898

—

Promyelocytes/Leukocytes in Blood
26524-9 [3021440]

1.3e+00

1.2e+00

2.3e+00

—

cases:7.85%

controls:2.36%

cases:5.76%

controls:1.83%

cases:3.14%

controls:0.31%

—

176

1865

180

1875

185

1904

—

Calcium [Moles/volume] in Serum or Plasma
2000-8 [3015377]

5.6e-01

1.5e+00

2.1e+00

—

cases:20.42%

controls:12.83%

cases:18.85%

controls:5.08%

cases:5.76%

controls:0.73%

—

245

152

1665

155

1813

180

1896

—

Erythrocytes [#/volume] in Urine
30391-7 [3002582]

6.4e-01

1.2e+00

2.4e+00

—

cases:20.42%

controls:11.94%

cases:19.90%

controls:7.02%

cases:7.85%

controls:0.79%

—

228

152

1682

134

153

1776

176

1895

—

Gas panel - Capillary blood
24337-8 [3022313]

1.4e+00

2.2e+00

—

cases:6.81%

controls:1.78%

cases:5.24%

controls:0.63%

—

178

1876

181

1898

—

prednisolone; oral, parenteral
H02AB06 [21602734]

8.3e-01

1.3e+00

1.4e+00

—

cases:27.75%

controls:14.40%

cases:23.04%

controls:7.28%

cases:5.24%

controls:1.36%

—

275

138

1635

139

147

1771

181

1884

—

prednisolone
A07EA01 [21600653]

8.3e-01

1.3e+00

1.4e+00

—

cases:27.75%

controls:14.40%

cases:23.04%

controls:7.28%

cases:5.24%

controls:1.36%

—

275

138

1635

139

147

1771

181

1884

—

Heart failure
I50 [45581779]

1.4e+00

2.1e+00

—

cases:6.81%

controls:1.78%

cases:7.33%

controls:0.94%

—

178

1876

177

1892

—

Blasts/Leukocytes in Blood
26446-5 [3025159]

1.3e+00

1.2e+00

2.2e+00

—

cases:6.81%

controls:2.04%

cases:5.76%

controls:1.73%

cases:3.14%

controls:0.37%

—

178

1871

180

1877

185

1903

—

Prealbumin [Mass/volume] in Serum or Plasma
14338-8 [3013742]

1.3e+00

2.1e+00

—

cases:8.90%

controls:2.62%

cases:6.81%

controls:0.89%

—

174

1860

178

1893

—

HIV 1 and 2 tests - Meaningful Use set
75622-1 [46235355]

1.2e+00

2.2e+00

—

cases:6.81%

controls:2.25%

cases:6.28%

controls:0.73%

—

178

1867

179

1896

—

Rheumatology
66 [38004491]

1.5e+00

1.8e+00

2.0e+00

—

cases:13.09%

controls:3.19%

cases:9.95%

controls:1.73%

cases:2.62%

controls:0.37%

—

166

1849

172

1877

186

1903

—

X-ray examination of the lungs in one projection
GD1PA [2001303645]

1.2e+00

2.1e+00

—

cases:6.28%

controls:1.88%

cases:5.24%

controls:0.68%

—

179

1874

181

1897

—

Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
6768-6 [3035995]

4.9e-01

1.1e+00

2.2e+00

1.0e+50

—

cases:46.60%

controls:34.92%

cases:43.98%

controls:20.37%

cases:25.65%

controls:3.66%

cases:4.19%

controls:0.00%

—

667

102

1243

389

107

1521

142

1840

183

1910

—

Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
2324-2 [3026910]

5.1e-01

1.1e+00

2.2e+00

—

cases:29.32%

controls:20.00%

cases:23.56%

controls:8.95%

cases:8.90%

controls:1.10%

—

382

135

1528

171

146

1739

174

1889

—

Glucose [Presence] in Urine by Test strip
25428-4 [3009261]

4.0e-01

1.1e+00

2.2e+00

—

cases:24.61%

controls:17.91%

cases:24.08%

controls:9.90%

cases:9.95%

controls:1.15%

—

342

144

1568

189

145

1721

172

1888

—

Urinalysis macro (dipstick) panel - Urine
24357-6 [3037467]

5.2e-01

1.1e+00

2.2e+00

—

cases:42.41%

controls:30.52%

cases:35.08%

controls:15.45%

cases:15.71%

controls:1.99%

—

583

110

1327

295

124

1615

161

1872

—

Nitrite [Presence] in Urine by Test strip
5802-4 [3021601]

3.9e-01

9.7e-01

2.3e+00

—

cases:23.56%

controls:17.28%

cases:22.51%

controls:9.90%

cases:9.95%

controls:1.10%

—

330

146

1580

189

148

1721

172

1889

—

Bacteria identified in Isolate by Culture
43409-2 [3042936]

1.0e+00

2.2e+00

—

cases:9.95%

controls:3.82%

cases:10.99%

controls:1.31%

—

172

1837

170

1885

—

Ketones [Presence] in Urine by Test strip
2514-8 [3035350]

3.2e-01

9.9e-01

2.2e+00

—

cases:23.04%

controls:17.85%

cases:23.04%

controls:10.00%

cases:9.95%

controls:1.15%

—

341

147

1569

191

147

1719

172

1888

—

Protein electrophoresis panel - 24 hour Urine
81231-3 [21494890]

3.2e+00

—

cases:7.33%

controls:0.31%

—

177

1904

—

Parathyrin.intact [Mass/volume] in Serum or Plasma
2731-8 [3000067]

1.5e+00

1.7e+00

—

cases:9.95%

controls:2.51%

cases:7.33%

controls:1.36%

—

172

1862

177

1884

—

Iron/Transferrin [Ratio] in Serum or Plasma
60517-0 [40763571]

1.6e+00

1.7e+00

—

cases:18.32%

controls:4.45%

cases:14.14%

controls:3.14%

cases:3.14%

controls:0.58%

—

156

1825

164

1850

185

1899

—

methotrexate
L01BA01 [21601423]

1.5e+00

1.7e+00

—

cases:6.81%

controls:1.62%

cases:5.76%

controls:1.10%

—

178

1879

180

1889

—

methotrexate; oral, parenteral
L04AX03 [21603929]

1.5e+00

1.7e+00

—

cases:6.81%

controls:1.62%

cases:5.76%

controls:1.10%

—

178

1879

180

1889

—

Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
76080-1 [46235759]

1.5e+00

1.7e+00

—

cases:5.24%

controls:1.26%

cases:4.19%

controls:0.79%

—

181

1886

183

1895

—

pH of Urine
2756-5 [3015736]

4.0e-01

7.9e-01

2.4e+00

—

cases:18.85%

controls:13.51%

cases:13.61%

controls:6.70%

cases:7.85%

controls:0.79%

—

258

155

1652

128

165

1782

176

1895

—

Albumin [Presence] in Urine by Test strip
50949-7 [3029937]

4.3e-01

1.0e+00

2.1e+00

—

cases:16.75%

controls:11.62%

cases:15.18%

controls:6.13%

cases:4.71%

controls:0.58%

—

222

159

1688

117

162

1793

182

1899

—

Complement C4 [Mass/volume] in Serum or Plasma
4498-2 [3017766]

3.1e+00

—

cases:5.76%

controls:0.26%

—

180

1905

—

Essential (primary) hypertension
I10 [45591453]

5.3e-01

7.6e-01

1.9e+00

—

cases:43.46%

controls:31.20%

cases:28.80%

controls:15.97%

cases:15.18%

controls:2.72%

—

596

108

1314

305

136

1605

162

1858

—

Normoblasts [#/volume] in Blood
715-3 [3021589]

6.3e-01

7.7e-01

1.7e+00

1.0e+50

—

cases:27.23%

controls:16.60%

cases:23.56%

controls:12.46%

cases:14.14%

controls:2.83%

cases:4.19%

controls:0.00%

—

317

139

1593

238

146

1672

164

1856

183

1910

—

Transferrin [Mass/volume] in Serum or Plasma
3034-6 [3004789]

1.6e+00

1.8e+00

—

cases:18.85%

controls:4.66%

cases:14.66%

controls:3.51%

cases:3.14%

controls:0.52%

—

155

1821

163

1843

185

1900

—

Leukocyte esterase [Presence] in Urine by Automated test strip
60026-2 [40763086]

3.1e-01

9.5e-01

2.2e+00

—

cases:19.90%

controls:15.45%

cases:17.80%

controls:7.75%

cases:6.81%

controls:0.84%

—

295

153

1615

148

157

1762

178

1894

—

alendronic acid; oral
M05BA04 [21604152]

1.4e+00

1.7e+00

—

cases:7.33%

controls:1.94%

cases:4.71%

controls:0.89%

—

177

1873

182

1893

—

Gas panel - Venous blood
24339-4 [3000991]

1.5e+00

1.6e+00

—

cases:7.85%

controls:1.83%

cases:5.76%

controls:1.26%

—

176

1875

180

1886

—

Erythrocytes [Presence] in Urine by Automated
53292-9 [3041096]

5.6e-01

1.2e+00

1.9e+00

—

cases:15.71%

controls:9.63%

cases:14.66%

controls:5.03%

cases:4.71%

controls:0.73%

—

184

161

1726

163

1814

182

1896

—

Case Management Agency
251B00000X [38004193]

3.7e-01

4.4e-01

8.5e-01

2.2e+00

—

cases:88.48%

controls:84.14%

cases:85.86%

controls:79.69%

cases:56.54%

controls:35.65%

cases:20.94%

controls:2.88%

—

169

1607

303

164

1522

388

108

681

1229

151

1855

—

Microscopic observation [Identifier] in Isolate by Gram stain
87975-9 [36305247]

1.2e+00

3.0e+00

—

cases:3.14%

controls:0.99%

cases:5.24%

controls:0.26%

—

185

1891

181

1905

—

Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method
4537-7 [3013707]

7.0e-01

8.6e-01

1.5e+00

—

cases:49.74%

controls:32.98%

cases:30.37%

controls:15.55%

cases:7.85%

controls:1.94%

—

630

1280

297

133

1613

176

1873

—

Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
40987-0 [3043924]

8.5e-01

1.2e+00

3.0e+00

—

cases:6.28%

controls:2.77%

cases:5.24%

controls:1.68%

cases:6.81%

controls:0.37%

—

179

1857

181

1878

178

1903

—

potassium chloride; oral
A12BA01 [21600877]

1.4e+00

1.6e+00

1.3e+00

—

cases:14.14%

controls:3.98%

cases:12.57%

controls:2.83%

cases:3.66%

controls:0.99%

—

164

1834

167

1856

184

1891

—

linagliptin; oral
A10BH05 [40251691]

1.6e+00

1.4e+00

—

cases:6.81%

controls:1.47%

cases:5.24%

controls:1.36%

—

178

1882

181

1884

—

Iron [Moles/volume] in Serum or Plasma
14798-3 [3022948]

1.4e+00

1.6e+00

—

cases:18.32%

controls:5.18%

cases:15.18%

controls:3.61%

cases:3.14%

controls:0.63%

—

156

1811

162

1841

185

1898

—

Complement C3 [Mass/volume] in Serum or Plasma
4485-9 [3000620]

3.0e+00

—

cases:5.76%

controls:0.31%

—

180

1904

—

Reticulocytes [#/volume] in Blood
14196-0 [3023520]

1.4e+00

1.6e+00

—

cases:12.57%

controls:3.56%

cases:8.38%

controls:1.83%

—

167

1842

175

1875

—

Bilirubin.conjugated [Moles/volume] in Serum or Plasma
29760-6 [3005772]

1.1e+00

1.8e+00

2.3e+00

—

cases:8.90%

controls:3.14%

cases:7.33%

controls:1.26%

cases:2.62%

controls:0.26%

—

174

1850

177

1886

186

1905

—

Other seropositive rheumatoid arthritis
M05.8 [45538634]

1.4e+00

1.5e+00

—

cases:5.76%

controls:1.47%

cases:5.24%

controls:1.20%

—

180

1882

181

1887

—

Magnesium [Moles/volume] in Serum or Plasma
2601-3 [3012095]

9.2e-01

2.0e+00

—

cases:11.52%

controls:4.92%

cases:13.09%

controls:2.09%

—

169

1816

166

1870

—

Hemoglobin [Mass/volume] in Capillary blood
30352-9 [3006184]

—

2.9e+00

—

cases:5.24%

controls:0.31%

—

181

1904

—

levofloxacin; inhalant, oral, parenteral
J01MA12 [21603019]

1.3e+00

1.5e+00

—

cases:9.42%

controls:2.77%

cases:4.71%

controls:1.05%

—

173

1857

182

1890

—

Home Visit
OMOP4822459 [581476]

5.3e-01

1.1e+00

1.7e+00

5.6e-01

—

cases:24.08%

controls:15.76%

cases:27.75%

controls:11.52%

cases:17.80%

controls:3.66%

cases:2.62%

controls:1.52%

—

301

145

1609

220

138

1690

157

1840

186

1881

—

Thorax X-ray examination outside radiological department
GD1UA [2001303652]

8.8e-01

2.8e+00

—

1.0e+50

—

cases:8.38%

controls:3.66%

cases:11.52%

controls:0.79%

—

cases:2.62%

controls:0.00%

—

175

1840

169

1895

—

186

1910

—

Fungus identified in Specimen by Culture
580-1 [3000494]

1.1e+00

1.7e+00

—

cases:7.85%

controls:2.83%

cases:4.71%

controls:0.89%

—

176

1856

182

1893

—

Standard cardiac ultrasound examination
FM1AE [2001303278]

1.3e+00

1.5e+00

—

cases:15.71%

controls:4.97%

cases:7.85%

controls:1.94%

—

161

1815

176

1873

—

Reticulocytes/Erythrocytes in Blood
4679-7 [3027945]

1.2e+00

1.5e+00

2.3e+00

—

cases:15.71%

controls:5.39%

cases:10.47%

controls:2.46%

cases:2.62%

controls:0.26%

—

103

161

1807

171

1863

186

1905

—

Protein [Mass/time] in 24 hour Urine
2889-4 [3020876]

2.7e+00

—

cases:5.76%

controls:0.42%

—

180

1902

—

Bacterial infection, unspecified
A49.9 [45590816]

1.1e+00

1.5e+00

2.7e+00

—

cases:6.28%

controls:2.20%

cases:4.19%

controls:0.99%

cases:3.66%

controls:0.26%

—

179

1868

183

1891

184

1905

—

Bone marrow biopsy
XW000 [2001310618]

1.1e+00

2.7e+00

—

cases:2.62%

controls:0.89%

cases:3.66%

controls:0.26%

—

186

1893

184

1905

—

Parathyrin.intact [Moles/volume] in Serum or Plasma
14866-8 [3010566]

2.7e+00

—

cases:3.66%

controls:0.26%

—

184

1905

—

Norovirus RNA [Presence] in Stool by NAA with probe detection
7974-9 [3008909]

1.5e+00

2.7e+00

—

cases:3.14%

controls:0.73%

cases:3.66%

controls:0.26%

—

185

1896

184

1905

—

Nursing episode
950 [44777714]

2.2e-01

1.1e+00

1.6e+00

—

cases:8.38%

controls:6.81%

cases:12.04%

controls:4.55%

cases:7.85%

controls:1.68%

—

130

175

1780

168

1823

176

1878

—

Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1742-6 [3006923]

1.3e-01

7.1e-01

1.9e+00

—

cases:61.78%

controls:58.64%

cases:60.21%

controls:42.62%

cases:32.46%

controls:6.44%

—

118

1120

790

115

814

1096

123

129

1787

—

Immunofixation for Serum or Plasma
25700-6 [3037756]

2.7e+00

—

cases:8.90%

controls:0.68%

—

174

1897

—

Hepatitis B virus surface Ag [Presence] in Serum
5195-3 [3019284]

1.2e+00

2.5e+00

—

cases:6.28%

controls:1.94%

cases:6.28%

controls:0.52%

—

179

1873

179

1900

—

sulfamethoxazole and trimethoprim
J01EE01 [21602961]

—

2.5e+00

—

cases:3.14%

controls:0.26%

—

185

1905

—

Metamyelocytes/Leukocytes in Blood
28541-1 [3002179]

1.0e+00

1.2e+00

2.5e+00

—

cases:6.28%

controls:2.30%

cases:5.76%

controls:1.73%

cases:3.14%

controls:0.26%

—

179

1866

180

1877

185

1905

—

Gas panel - Central venous blood
97535-9 [1616796]

1.5e+00

2.5e+00

—

cases:2.62%

controls:0.58%

cases:3.14%

controls:0.26%

—

186

1899

185

1905

—

Monoclonal gammopathy of undetermined significance (MGUS)
D47.2 [45566693]

2.5e+00

—

cases:3.14%

controls:0.26%

—

185

1905

—

Puncture of pleura with ultrasound guidance
GA4YT [2001303531]

2.5e+00

—

1.0e+50

—

cases:3.14%

controls:0.26%

—

cases:3.66%

controls:0.00%

—

185

1905

—

184

1910

—

Cardiomyopathy, unspecified
I42.9 [45581773]

2.5e+00

—

cases:3.66%

controls:0.31%

—

184

1904

—

Oxygen saturation in Capillary blood
2709-4 [3021901]

—

2.5e+00

—

cases:3.66%

controls:0.31%

—

184

1904

—

Upper gastrointestinal surgery
106 [44777669]

6.0e-01

8.5e-01

1.9e+00

—

cases:24.61%

controls:15.13%

cases:10.99%

controls:5.03%

cases:3.66%

controls:0.58%

—

289

144

1621

170

1814

184

1899

—

Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
27811-9 [3000515]

2.5e+00

—

cases:4.19%

controls:0.37%

—

183

1903

—

Chronic arrhythmias
207 [2001600205]

8.1e-01

1.7e+00

—

cases:13.09%

controls:6.28%

cases:6.28%

controls:1.26%

—

120

166

1790

179

1886

—

Bicarbonate [Moles/volume] standard in Capillary blood
19231-0 [3004490]

1.3e+00

2.5e+00

—

cases:5.76%

controls:1.68%

cases:4.71%

controls:0.42%

—

180

1878

182

1902

—

Hemoglobin [Presence] in Urine by Test strip
5794-3 [3011397]

0.0e+00

7.0e-01

2.5e+00

—

cases:7.85%

controls:7.85%

cases:8.38%

controls:4.35%

cases:4.71%

controls:0.42%

—

150

176

1760

175

1827

182

1902

—

Extensive structural and functional ultrasound examination of heart
FM1EE [2001303307]

1.0e+00

1.4e+00

—

cases:17.80%

controls:7.28%

cases:12.57%

controls:3.35%

—

139

157

1771

167

1846

—

Limited function/disability NOS
A28 [2002000162]

4.2e-01

1.2e+00

1.3e+00

—

cases:10.99%

controls:7.49%

cases:15.71%

controls:5.45%

cases:7.33%

controls:2.20%

—

143

170

1767

104

161

1806

177

1868

—

Angiography of heart and/or coronary arteries
FN1AC [2001302996]

9.9e-01

1.4e+00

—

cases:14.66%

controls:6.02%

cases:5.24%

controls:1.36%

—

115

163

1795

181

1884

—

lactulose; oral
A06AD11 [21600571]

9.4e-01

1.4e+00

—

cases:9.95%

controls:4.14%

cases:8.38%

controls:2.15%

—

172

1831

175

1869

—

Hepatitis C virus Ab [Presence] in Serum
16128-1 [3017143]

1.1e+00

2.4e+00

—

cases:6.28%

controls:2.09%

cases:6.28%

controls:0.63%

—

179

1870

179

1898

—

Protein [Presence] in Urine by Test strip
20454-5 [3014051]

2.4e-01

7.9e-01

2.3e+00

—

cases:7.33%

controls:5.86%

cases:7.85%

controls:3.72%

cases:5.24%

controls:0.52%

—

112

177

1798

176

1839

181

1900

—

Hepatitis B virus core Ab [Presence] in Serum
16933-4 [3021879]

1.4e+00

2.3e+00

—

cases:4.19%

controls:1.10%

cases:4.71%

controls:0.47%

—

183

1889

182

1901

—

Protein [Mass] in Urine collected for unspecified duration
32551-4 [3017817]

2.3e+00

—

cases:4.19%

controls:0.42%

—

183

1902

—

Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
3255-7 [3016407]

2.3e+00

—

cases:3.66%

controls:0.37%

—

184

1903

—

darbepoetin alfa; parenteral
B03XA02 [21601134]

2.3e+00

—

cases:2.62%

controls:0.26%

cases:3.66%

controls:0.37%

—

186

1905

184

1903

—

Oxygen [Partial pressure] in Capillary blood
2704-5 [3028626]

—

2.3e+00

—

cases:3.66%

controls:0.37%

—

184

1903

—

Myoglobin [Mass/volume] in Serum or Plasma
2639-3 [3005895]

1.2e+00

2.3e+00

—

cases:4.19%

controls:1.31%

cases:3.14%

controls:0.31%

—

183

1885

185

1904

—

Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
54067-4 [3051552]

5.8e-01

2.3e+00

—

cases:3.66%

controls:2.09%

cases:6.28%

controls:0.68%

—

184

1870

179

1897

—

Thorax CT examination
GD1AD [2001303618]

1.0e+00

2.2e+00

—

cases:3.14%

controls:1.15%

cases:3.66%

controls:0.42%

—

185

1888

184

1902

—

Specific gravity of Urine by Refractometry
5810-7 [3019150]

2.0e-01

5.4e-01

2.2e+00

—

cases:9.95%

controls:8.32%

cases:6.81%

controls:4.08%

cases:3.66%

controls:0.42%

—

159

172

1751

178

1832

184

1902

—

Vancomycin [Susceptibility]
19000-9 [3014271]

2.2e+00

—

cases:3.14%

controls:0.37%

—

185

1903

—

Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
47826-3 [3052649]

2.2e+00

—

cases:3.14%

controls:0.37%

—

185

1903

—

Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
3216-9 [3020427]

8.7e-01

2.1e+00

—

cases:3.66%

controls:1.57%

cases:4.71%

controls:0.58%

—

184

1880

182

1899

—

Limited function/disability (L)
L28 [2002000647]

8.9e-01

1.2e+00

1.8e+00

—

cases:10.99%

controls:4.82%

cases:8.90%

controls:2.77%

cases:3.14%

controls:0.52%

—

170

1818

174

1857

185

1900

—

pantoprazole; oral, parenteral
A02BC02 [21600097]

9.3e-01

1.2e+00

8.6e-01

—

cases:46.60%

controls:25.65%

cases:36.65%

controls:14.97%

cases:9.95%

controls:4.45%

—

490

102

1420

286

121

1624

172

1825

—

Myeloperoxidase IgG Ab [Units/volume] in Serum
48404-8 [3049804]

2.1e+00

—

cases:4.19%

controls:0.52%

—

183

1900

—

Bicarbonate [Moles/volume] in Capillary blood
1961-2 [3015235]

—

2.1e+00

—

cases:4.19%

controls:0.52%

—

183

1900

—

Cortisol [Moles/volume] in Serum or Plasma
14675-3 [3036481]

3.6e-01

2.1e+00

—

cases:2.62%

controls:1.83%

cases:5.76%

controls:0.73%

—

186

1875

180

1896

—

Folate [Moles/volume] in Red Blood Cells
14731-4 [3019309]

6.8e-01

1.4e+00

—

cases:20.42%

controls:11.47%

cases:8.90%

controls:2.36%

—

219

152

1691

174

1865

—

Metabolic syndrome
E66.00 [2000501500]

2.1e+00

—

cases:3.66%

controls:0.47%

—

184

1901

—

Persistent atrial fibrillation
I48.1 [45548021]

1.3e+00

2.1e+00

—

cases:3.14%

controls:0.89%

cases:6.28%

controls:0.84%

—

185

1893

179

1894

—

Bacteria identified in Urine by Culture
630-4 [3026008]

1.6e-01

6.9e-01

2.1e+00

—

cases:15.71%

controls:13.66%

cases:13.09%

controls:7.02%

cases:6.28%

controls:0.84%

—

261

161

1649

134

166

1776

179

1894

—

Morphology [Interpretation] in Bone marrow Narrative
51628-6 [3042111]

2.1e+00

—

cases:4.71%

controls:0.63%

—

182

1898

—

Pleural effusion, not elsewhere classified
J90 [45605897]

2.1e+00

—

cases:4.71%

controls:0.63%

—

182

1898

—

Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
35704-6 [3036428]

2.0e+00

—

cases:3.14%

controls:0.42%

—

185

1902

—

Urinary tract ultrasound examination
KH1AE [2001306329]

1.4e+00

2.0e+00

—

cases:3.66%

controls:0.94%

cases:3.14%

controls:0.42%

—

184

1892

185

1902

—

Sodium and Potassium panel [Moles/volume] - Serum or Plasma
34548-8 [3045783]

8.7e-02

5.7e-01

2.0e+00

—

cases:8.90%

controls:8.22%

cases:4.71%

controls:2.72%

cases:3.14%

controls:0.42%

—

157

174

1753

182

1858

185

1902

—

Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
3209-4 [3019250]

2.0e+00

—

cases:3.14%

controls:0.42%

—

185

1902

—

formoterol, glycopyrronium bromide and beclometasone
R03AL09 [1502099]

1.8e+00

2.0e+00

—

cases:3.14%

controls:0.52%

cases:3.14%

controls:0.42%

—

185

1900

185

1902

—

Corns and callosities
L84 [45533651]

2.0e+00

—

cases:3.14%

controls:0.42%

—

185

1902

—

Protein electrophoresis panel - Urine
34539-7 [3044927]

2.0e+00

—

cases:3.14%

controls:0.42%

—

185

1902

—

Digoxin [Moles/volume] in Serum or Plasma
14698-5 [3027456]

1.4e+00

2.0e+00

—

cases:4.71%

controls:1.15%

cases:3.14%

controls:0.42%

—

182

1888

185

1902

—

Oxygen content in Capillary blood by calculation
64799-0 [40767503]

1.2e+00

2.0e+00

—

cases:2.62%

controls:0.79%

cases:3.14%

controls:0.42%

—

186

1895

185

1902

—

Thrombin time
3243-3 [3036489]

2.0e+00

—

cases:4.19%

controls:0.58%

—

183

1899

—

Procalcitonin [Mass/volume] in Serum or Plasma
33959-8 [3046279]

1.1e+00

2.0e+00

—

cases:3.14%

controls:1.10%

cases:4.19%

controls:0.58%

—

185

1889

183

1899

—

Mycobacterium sp identified in Specimen by Organism specific culture
543-9 [3005702]

2.0e+00

—

cases:3.66%

controls:0.52%

—

184

1900

—

Cardiodefibrillation
TFP20 [2001303224]

1.9e+00

—

cases:7.85%

controls:1.20%

—

176

1887

—

Bicarbonate [Moles/volume] in Serum or Plasma
1963-8 [3016293]

1.2e+00

1.9e+00

—

cases:4.71%

controls:1.47%

cases:5.76%

controls:0.89%

—

182

1882

180

1893

—

DNA double strand Ab [Units/volume] in Serum
5130-0 [3023420]

1.9e+00

—

cases:3.66%

controls:0.58%

—

184

1899

—

Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1920-8 [3013721]

6.2e-01

6.9e-01

1.9e+00

—

cases:15.18%

controls:8.80%

cases:7.85%

controls:4.08%

cases:3.66%

controls:0.58%

—

168

162

1742

176

1832

184

1899

—

Arthrocentesis, unspecified region, unspecified region
TNX10 [2001308560]

1.9e+00

—

cases:4.19%

controls:0.68%

—

183

1897

—

Guidance concerning treatment of rash and skin
SPAT1156 [2001700257]

3.7e-01

1.2e+00

1.9e+00

—

cases:7.33%

controls:5.18%

cases:6.28%

controls:1.99%

cases:4.19%

controls:0.68%

—

177

1811

179

1872

183

1897

—

calcium (different salts in combination); oral
A12AA20 [21600872]

8.2e-01

1.0e+00

3.3e-01

—

cases:27.23%

controls:14.14%

cases:27.23%

controls:11.78%

cases:5.24%

controls:3.82%

—

270

139

1640

225

139

1685

181

1837

—

Urate [Moles/volume] in Serum or Plasma
14933-6 [3026493]

7.3e-01

1.1e+00

1.5e+00

—

cases:19.90%

controls:10.68%

cases:11.52%

controls:4.14%

cases:3.14%

controls:0.73%

—

204

153

1706

169

1831

185

1896

—

fluconazole; oral, parenteral
J02AC01 [21603080]

4.9e-01

1.8e+00

—

cases:4.71%

controls:2.93%

cases:4.71%

controls:0.79%

—

182

1854

182

1895

—

Band form neutrophils/Leukocytes in Blood
26508-2 [3004809]

1.8e+00

—

cases:3.66%

controls:0.63%

—

184

1898

—

Acute bronchitis, unspecified
J20.9 [45562445]

7.8e-01

1.8e+00

—

cases:7.85%

controls:3.77%

cases:3.66%

controls:0.63%

—

176

1838

184

1898

—

Thoracic and Cardiac Surgery
OMOP4822009 [45756830]

5.1e-01

1.8e+00

—

cases:4.19%

controls:2.57%

cases:4.19%

controls:0.73%

—

183

1861

183

1896

—

Neutrophil cytoplasmic Ab [Units/volume] in Serum
5128-4 [3001334]

1.8e+00

—

cases:5.24%

controls:0.94%

—

181

1892

—

Bicarbonate [Moles/volume] standard in Venous blood
19232-8 [3007628]

1.8e+00

1.2e+00

—

cases:5.76%

controls:1.05%

cases:3.14%

controls:0.94%

—

180

1890

185

1892

—

Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
2742-5 [3034780]

1.7e+00

—

cases:6.81%

controls:1.26%

—

178

1886

—

Erythrocyte [DistWidth] in Red Blood Cells
30385-9 [3002385]

1.3e-01

4.3e-01

1.7e+00

—

cases:42.93%

controls:39.84%

cases:42.41%

controls:32.46%

cases:29.84%

controls:7.17%

—

761

109

1149

620

110

1290

137

134

1773

—

Bacteria identified in Skin by Aerobe culture
620-5 [3007853]

4.2e-01

1.7e+00

—

cases:7.33%

controls:4.92%

cases:6.81%

controls:1.31%

—

177

1816

178

1885

—

Lactate [Moles/volume] in Serum or Plasma
2524-7 [3014111]

9.0e-01

1.7e+00

—

cases:5.24%

controls:2.20%

cases:6.81%

controls:1.31%

—

181

1868

178

1885

—

Lysozyme [Mass/volume] in Serum or Plasma
2589-0 [3012110]

1.7e+00

—

cases:4.71%

controls:0.89%

—

182

1893

—

Proteinase 3 Ab [Units/volume] in Serum
6968-2 [3009445]

1.7e+00

—

cases:5.24%

controls:0.99%

—

181

1891

—

Orthopedic Surgery
20 [38004465]

3.8e-01

5.9e-01

1.7e+00

—

cases:26.70%

controls:19.90%

cases:11.52%

controls:6.70%

cases:6.28%

controls:1.26%

—

380

140

1530

128

169

1782

179

1886

—

Tissue Pathology biopsy report
66121-5 [40768804]

7.2e-01

9.4e-01

—

cases:26.18%

controls:14.76%

cases:12.57%

controls:5.34%

—

282

141

1628

102

167

1808

—

Hypertensive heart disease without (congestive) heart failure
I11.9 [45576863]

1.6e+00

—

cases:4.71%

controls:0.94%

—

182

1892

—

Complement+Immunoglobulin [Units/volume] in Red Blood Cells
4533-6 [3024403]

1.6e+00

—

cases:4.71%

controls:0.94%

—

182

1892

—

Measurement of bone density from two or more locations with X-ray
NK6QA [2001308500]

1.6e+00

—

cases:4.71%

controls:0.94%

—

182

1892

—

Other gastroenteritis and colitis of infectious and unspecified origin
A09 [45605189]

9.3e-01

1.6e+00

—

cases:5.76%

controls:2.36%

cases:4.71%

controls:0.94%

—

180

1865

182

1892

—

Abdominal CT examination
JN3AD [2001305554]

1.2e+00

1.6e+00

1.0e+50

—

cases:6.28%

controls:1.99%

cases:4.19%

controls:0.84%

cases:3.14%

controls:0.00%

—

179

1872

183

1894

185

1910

—

Taking care of patient’s/customer’s hygiene
SPAT1137 [2001700238]

6.0e-01

1.2e+00

1.6e+00

—

cases:3.66%

controls:2.04%

cases:5.76%

controls:1.73%

cases:4.19%

controls:0.84%

—

184

1871

180

1877

183

1894

—

Gas panel - Arterial blood
24336-0 [3019060]

4.5e-01

1.6e+00

—

cases:4.19%

controls:2.72%

cases:4.19%

controls:0.84%

—

183

1858

183

1894

—

enoxaparin; parenteral
B01AB05 [21600976]

5.8e-01

1.6e+00

—

cases:13.61%

controls:8.12%

cases:10.99%

controls:2.36%

—

155

165

1755

170

1865

—

Aortic (valve) stenosis
I35.0 [45576869]

4.6e-01

1.6e+00

—

1.0e+50

—

cases:3.66%

controls:2.36%

cases:6.28%

controls:1.31%

—

cases:4.19%

controls:0.00%

—

184

1865

179

1885

—

183

1910

—

Bicarbonate [Moles/volume] standard in Arterial blood
19230-2 [3014218]

8.4e-01

1.6e+00

—

cases:2.62%

controls:1.15%

cases:5.24%

controls:1.10%

—

186

1888

181

1889

—

Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
40988-8 [3044254]

1.6e+00

—

cases:4.71%

controls:0.99%

cases:3.66%

controls:0.79%

—

182

1891

184

1895

—

Oxygen [Partial pressure] in Arterial blood
2703-7 [3027801]

2.3e-01

1.5e+00

—

cases:4.71%

controls:3.77%

cases:7.85%

controls:1.78%

—

182

1838

176

1876

—

Carbon dioxide [Partial pressure] in Arterial blood
2019-8 [3027946]

3.4e-01

1.5e+00

—

cases:5.24%

controls:3.77%

cases:7.85%

controls:1.78%

—

181

1838

176

1876

—

Microorganisms panel - Urine sediment
58435-9 [40761536]

6.1e-01

1.5e+00

—

cases:7.33%

controls:4.14%

cases:7.85%

controls:1.78%

—

177

1831

176

1876

—

Emergency use of U07.1 | COVID-19, virus identified
U07.1 [45756093]

—

1.5e+00

—

cases:4.71%

controls:1.05%

—

182

1890

—

Physiotherapy
R4110 [2001310233]

5.6e-01

1.5e+00

—

cases:11.52%

controls:6.91%

cases:10.47%

controls:2.46%

—

132

169

1778

171

1863

—

Other diagnostic examination of periferal vessel
XPX99 [2001309755]

1.5e+00

—

cases:5.76%

controls:1.31%

—

180

1885

—

pH of Arterial blood
2744-1 [3019977]

3.2e-01

1.5e+00

—

cases:5.24%

controls:3.87%

cases:7.85%

controls:1.83%

—

181

1836

176

1875

—

Base excess in Arterial blood by calculation
1925-7 [3003396]

3.4e-01

1.5e+00

—

cases:5.24%

controls:3.77%

cases:7.85%

controls:1.83%

—

181

1838

176

1875

—

aciclovir; oral, parenteral
J05AB01 [21603131]

7.2e-01

1.5e+00

—

cases:5.24%

controls:2.62%

cases:5.24%

controls:1.20%

—

181

1860

181

1887

—

Carbon dioxide [Partial pressure] in Venous blood
2021-4 [3021447]

1.5e+00

1.2e+00

—

cases:9.42%

controls:2.25%

cases:4.71%

controls:1.52%

—

173

1867

182

1881

—

Calcium [Moles/volume] corrected for albumin in Serum or Plasma
29265-6 [3020059]

6.2e-01

1.5e+00

—

cases:13.09%

controls:7.49%

cases:11.52%

controls:2.83%

—

143

166

1767

169

1856

—

ABO and Rh group [Type] in Blood by Confirmatory method
77397-8 [46236098]

6.9e-01

1.5e+00

—

cases:15.71%

controls:8.59%

cases:15.71%

controls:4.03%

—

164

161

1746

161

1833

—

Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
47598-8 [3048816]

6.3e-01

1.5e+00

—

cases:6.28%

controls:3.46%

cases:6.81%

controls:1.62%

—

179

1844

178

1879

—

Base excess in Venous blood by calculation
1927-3 [3002032]

1.5e+00

1.3e+00

—

cases:9.42%

controls:2.30%

cases:5.24%

controls:1.41%

—

173

1866

181

1883

—

pH of Venous blood
2746-6 [3012544]

1.5e+00

1.3e+00

—

cases:9.42%

controls:2.30%

cases:5.24%

controls:1.52%

—

173

1866

181

1881

—

Nuclear Ab [Titer] in Serum
29953-7 [3037522]

1.5e+00

9.3e-01

—

cases:9.95%

controls:2.46%

cases:2.62%

controls:1.05%

—

172

1863

186

1890

—

Support of social functional capacity
SPAT1234 [2001700335]

5.5e-01

1.5e+00

1.8e+00

—

cases:3.14%

controls:1.83%

cases:5.24%

controls:1.26%

cases:3.14%

controls:0.52%

—

185

1875

181

1886

185

1900

—

Body CT examination
JN4AD [2001310897]

1.5e+00

6.3e-01

—

cases:6.81%

controls:1.68%

cases:2.62%

controls:1.41%

—

178

1878

186

1883

—

bisoprolol; oral
C07AB07 [21601689]

7.2e-01

3.2e-01

—

cases:46.07%

controls:29.37%

cases:43.46%

controls:27.23%

cases:12.57%

controls:9.42%

—

561

103

1349

520

108

1390

180

167

1730

—

25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
68438-1 [40771025]

6.6e-01

7.8e-01

—

cases:24.08%

controls:14.08%

cases:15.18%

controls:7.59%

—

269

145

1641

145

162

1765

—

Type 2 diabetes mellitus, with unspecified complications
E11.8 [45561951]

3.0e-01

1.4e+00

2.1e+00

—

cases:3.14%

controls:2.36%

cases:5.24%

controls:1.31%

cases:2.62%

controls:0.31%

—

185

1865

181

1885

186

1904

—

Oxygen saturation in Arterial blood
2708-6 [3016502]

3.1e-01

1.4e+00

—

cases:4.71%

controls:3.51%

cases:6.81%

controls:1.73%

—

182

1843

178

1877

—

Creatine kinase.MB [Mass/volume] in Serum or Plasma
13969-1 [3005785]

8.5e-01

1.4e+00

—

cases:9.42%

controls:4.24%

cases:6.81%

controls:1.78%

—

173

1829

178

1876

—

Administration of medicine
SPAT1254 [2001700355]

2.8e-01

6.0e-01

1.4e+00

—

cases:6.28%

controls:4.82%

cases:5.24%

controls:2.93%

cases:5.24%

controls:1.36%

—

179

1818

181

1854

181

1884

—

Infectious Disease
44 [38004484]

1.1e+00

1.4e+00

-1.0e+50

—

cases:6.28%

controls:2.15%

cases:5.24%

controls:1.36%

cases:0.00%

controls:0.26%

—

179

1869

181

1884

191

1905

—

Endocrinology
46 [38004485]

5.8e-01

1.4e+00

—

cases:3.66%

controls:2.09%

cases:5.24%

controls:1.36%

—

184

1870

181

1884

—

Chloride [Moles/volume] in Serum or Plasma
2075-0 [3014576]

5.8e-01

1.4e+00

—

cases:7.33%

controls:4.24%

cases:7.85%

controls:2.09%

—

177

1829

176

1870

—

Ultrasound examination of lower leg veins
PH2AE [2001309451]

1.4e+00

—

cases:8.90%

controls:2.46%

—

174

1863

—

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

19.41

66.95

5.4

2.0

1.21

1.53

ratio

0.95

(3034860) Kappa light chains.free [Mass/volume] in Serum

18.11

64.46

5.9

2.4

35.92

181.57

mg/l

0.54

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

18.11

64.46

5.8

2.4

59.73

34.10

mg/l

0.95

(3004588) Protein electrophoresis panel - Serum or Plasma

120

6.83

30.88

4.1

1.7

—

(3037756) Immunofixation for Serum or Plasma

10.43

30.33

1.7

1.2

—

(21494890) Protein electrophoresis panel - 24 hour Urine

25.13

21.61

2.3

1.2

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

6.35

18.35

4.6

1.4

0.63

0.34

g/l

0.43

(3020876) Protein [Mass/time] in 24 hour Urine

22.90

18.32

2.9

2.2

1.05

1.40

g/24h

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

6.40

13.07

3.7

2.4

0.31

0.32

iu/ml

0.06

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

110

591

3.03

12.76

7.1

3.3

4828.44

1657.19

ng/l

6.02

100

509

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

4.24

11.87

5.8

4.0

1.42

2.27

mmol/l

0.57

(3027945) Reticulocytes/Erythrocytes in Blood

230

3.11

10.74

2.2

3.0

1.84

1.72

0.32

206

(3004269) Kappa light chains [Mass/time] in 24 hour Urine

+∞

10.51

2.7

0.0

—

(4035726) Immunohistochemistry procedure

137

3.54

10.47

1.4

1.3

—

(3032080) INR in Blood by Coagulation assay

127

790

2.81

10.39

24.1

18.8

1.45

1.39

inr

0.57

109

657

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

110

643

2.68

10.08

7.9

4.2

76.54

48.41

ng/l

1.20

507

(3023368) Bacteria identified in Blood by Culture

477

2.68

10.06

6.4

4.6

—

(3013115) Eosinophils [#/volume] in Blood

121

746

2.70

9.88

7.8

5.8

0.16

0.19

e9/l

1.06

110

651

(3006315) Basophils [#/volume] in Blood

119

728

2.68

9.87

7.6

5.6

0.03

0.04

e9/l

0.56

110

626

(3019198) Lymphocytes [#/volume] in Blood

119

732

2.66

9.69

7.8

5.7

1.49

1.72

e9/l

2.49

111

647

(3001604) Monocytes [#/volume] in Blood

118

723

2.65

9.69

7.7

5.6

0.63

0.62

e9/l

0.23

109

620

(3042111) Morphology [Interpretation] in Bone marrow Narrative

5.33

9.55

1.1

1.6

—

(3023520) Reticulocytes [#/volume] in Blood

175

3.15

9.48

2.0

3.1

71.27

64.15

e9/l

0.53

134

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

+∞

9.45

2.8

0.0

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

115

704

2.59

9.33

9.1

4.1

33.31

34.36

g/l

0.97

107

651

(3007164) IgA [Mass/volume] in Serum or Plasma

229

2.89

9.18

3.1

1.4

2.59

3.15

g/l

0.56

123

(3019069) Monocytes/Leukocytes in Blood

112

681

2.56

9.16

8.4

5.7

9.09

9.12

0.03

107

638

(3018677) aPTT in Platelet poor plasma by Coagulation assay

231

2.86

9.02

2.6

1.9

29.69

29.71

0.01

220

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

3.72

8.78

1.7

2.4

1.33

1.61

g/l

0.84

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

125

812

2.56

8.71

16.1

5.7

1.20

1.21

mmol/l

0.63

113

678

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

115

728

2.46

8.34

14.2

5.5

1.20

1.21

mmol/l

0.04

110

651

(3012441) Differential panel - Pleural fluid

7.83

8.18

1.2

1.5

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

305

2.59

8.18

2.1

1.9

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

101

3.47

8.14

8.7

3.2

161.08

95.03

ng/l

1.68

(42870588) Differential panel, method unspecified - Blood

495

2.39

7.91

7.2

5.5

—

(3022948) Iron [Moles/volume] in Serum or Plasma

274

2.60

7.88

5.0

2.3

10.29

12.13

umol/l

1.22

248

(3013650) Neutrophils [#/volume] in Blood by Automated count

122

813

2.39

7.60

11.0

9.3

4.84

4.28

e9/l

1.10

113

711

(3019309) Folate [Moles/volume] in Red Blood Cells

353

2.44

7.52

1.9

1.7

995.80

1170.89

nmol/l

0.97

270

(3022313) Gas panel - Capillary blood

3.56

7.28

5.5

3.9

—

(3026493) Urate [Moles/volume] in Serum or Plasma

367

2.38

7.18

4.6

2.6

415.06

360.23

umol/l

2.38

310

(3017817) Protein [Mass] in Urine collected for unspecified duration

10.63

7.15

1.8

1.4

347.38

652.69

0.29

(3012544) pH of Venous blood

152

2.87

7.06

6.7

3.4

7.38

7.39

0.28

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

548

2.21

6.70

5.1

3.4

—

(3002032) Base excess in Venous blood by calculation

150

2.82

6.69

7.0

3.4

2.14

1.95

mmol/l

0.12

126

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

18.79

6.32

1.1

1.0

—

(40768446) Kidney Pathology biopsy report

+∞

6.28

1.2

0.0

—

(1616796) Gas panel - Central venous blood

6.41

6.14

2.9

2.7

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

4.05

5.96

3.4

2.1

117.55

123.00

g/l

0.36

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

3.73

5.90

1.5

1.2

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

110

2.93

5.89

2.5

1.4

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

6.48

5.81

1.2

1.5

3193.40

43334.23

e6/l

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

123

2.81

5.81

2.4

1.4

—

(3007853) Bacteria identified in Skin by Aerobe culture

155

2.63

5.77

2.7

1.7

—

(3045142) Bone marrow Pathology biopsy report

6.89

5.66

1.1

1.3

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

114

2.82

5.52

1.9

1.8

—

(3028626) Oxygen [Partial pressure] in Capillary blood

3.97

5.49

2.6

2.7

8.16

8.00

kpa

0.13

(3023199) Leukocytes [#/volume] in Pleural fluid

5.95

5.49

1.2

1.4

636.56

900.89

e6/l

—

(3036603) Volume of Urine

16.60

5.46

1.4

1622.50

1958.00

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

9.52

5.35

2.7

2.6

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

3.14

5.23

2.2

1.2

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

3.51

5.17

3.2

2.6

24.16

25.85

mmol/l

1.08

(3037121) Protein [Mass/volume] in Urine

3.51

5.17

2.2

3.6

312.20

178.33

mg/l

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

3.79

5.17

3.4

1.4

—

(3000991) Gas panel - Venous blood

132

2.61

5.06

15.1

8.1

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

5.31

5.05

2.1

1.1

—

(3030467) Casts [#/volume] in Urine by Automated count

422

2.04

5.04

5.1

3.2

0.65

0.46

e6/l

0.38

313

(3021901) Oxygen saturation in Capillary blood

4.84

4.99

2.7

3.0

88.85

89.75

0.11

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

4.84

4.99

2.9

1.2

0.21

0.23

g/l

0.28

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

451

2.00

4.89

2.6

2.2

3.21

3.19

mg/l

0.02

390

(3044640) Blood type and Crossmatch panel - Blood

479

1.97

4.79

3.3

2.9

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

4.56

4.75

2.9

1.3

1.16

1.12

g/l

0.18

(3002582) Erythrocytes [#/volume] in Urine

493

1.94

4.60

5.2

3.4

55.91

224.11

e6/l

0.65

379

(3018095) Leukocytes [#/volume] in Urine

545

1.92

4.60

6.1

3.8

67.82

110.89

e6/l

0.56

390

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

210

2.21

4.45

2.0

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

5.77

4.36

1.6

1.2

—

(40768806) Pleura Pathology biopsy report

4.73

4.33

1.9

1.5

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

7.20

4.21

1.1

—

(3044927) Protein electrophoresis panel - Urine

7.20

4.21

1.2

—

(3018418) pH of Serum or Plasma

479

1.89

4.20

10.0

3.7

7.39

7.40

0.29

351

(3001122) Ferritin [Mass/volume] in Serum or Plasma

612

1.85

4.17

4.7

2.7

157.54

160.07

ug/l

0.04

547

(3042936) Bacteria identified in Isolate by Culture

231

2.11

4.13

3.3

2.0

—

(40768804) Tissue Pathology biopsy report

552

1.85

4.10

2.3

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

3.00

4.08

1.8

1.6

—

(3019225) pH of Specimen

162

2.25

3.95

7.6

3.4

7.36

0.06

107

(3000850) Epithelial cells [#/volume] in Urine

337

1.94

3.92

4.2

2.7

3.34

4.41

e6/l

0.82

306

(3014271) Vancomycin [Susceptibility]

9.02

3.80

2.4

2.5

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

3.28

3.73

1.9

1.4

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

225

2.05

3.71

1.9

—

(3017704) Immunofixation for Urine

8.02

3.59

2.0

1.0

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

4.06

3.56

1.4

1.1

—

(3037522) Nuclear Ab [Titer] in Serum

155

2.19

3.55

1.5

1.3

432.00

565.52

titre

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

6.37

3.54

1.3

1.2

—

(3012501) Base excess in Blood by calculation

3.93

3.45

3.3

2.0

2.37

2.46

mmol/l

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

657

1.74

3.44

3.4

3.2

—

estimate

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

5.19

3.41

4.7

1.7

11.91

6.80

pmol/l

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

158

1343

2.02

3.39

37.6

18.2

26.96

28.31

mg/l

0.23

145

1149

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

2.66

3.32

2.1

1.8

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

145

2.18

3.32

2.8

1.6

—

(3009508) Creatinine [Moles/volume] in Urine

500

1.74

3.30

2.7

3.0

5.94

7.13

mmol/l

1.81

408

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

8.80

3.28

1.0

1.4

108.17

111.29

pmol/l

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

599

1.72

3.28

2.6

2.4

—

(3045788) Cell count panel - Pleural fluid

4.91

3.28

1.4

1.5

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

365

1.80

3.23

2.9

3.0

—

(3012516) Albumin [Mass/volume] in Urine

494

1.73

3.22

3.0

3.1

129.36

46.92

mg/l

1.56

324

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

3.41

3.21

4.0

1.6

2.68

1.60

mg/l

1.89

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

3.41

3.21

1.2

1.5

—

(3020682) Albumin/Creatinine [Ratio] in Urine

513

1.72

3.18

3.6

3.7

35.05

8.53

mg/mmol

1.83

318

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

3.03

3.09

1.7

1.1

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

2.51

2.99

1.9

3.1

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

2.33

2.96

1.7

1.4

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

103

792

1.65

2.93

3.6

3.0

55.29

55.03

u/l

0.01

729

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

5.54

2.89

1.4

1.1

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

551

1.67

2.89

4.3

2.9

2.35

2.34

mmol/l

0.04

494

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

238

1.86

2.84

4.5

3.1

2.15

1.66

e6/l

0.13

126

(3003396) Base excess in Arterial blood by calculation

207

1.91

2.83

9.9

6.8

1.04

1.30

mmol/l

0.15

165

(3020564) Creatinine [Moles/volume] in Serum or Plasma

163

1429

1.96

2.78

45.0

24.0

111.06

83.94

umol/l

4.62

157

1406

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

3.37

2.77

1.1

1.3

—

(3026008) Bacteria identified in Urine by Culture

502

1.66

2.77

3.6

3.3

—

(3000494) Fungus identified in Specimen by Culture

164

1.98

2.73

1.8

1.5

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

161

1410

1.90

2.70

45.5

21.6

4.02

mmol/l

0.07

155

1370

(3019550) Sodium [Moles/volume] in Serum or Plasma

161

1410

1.90

2.70

44.6

21.5

138.95

139.74

mmol/l

2.58

155

1371

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

3.72

2.61

1.1

1.2

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

4.13

2.60

1.4

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

160

1405

1.86

2.57

16.9

12.1

22.51

23.40

u/l

0.51

152

1350

(3004616) Nuclear Ab [Presence] in Serum

5.59

2.56

1.2

1.3

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

131

2.05

2.55

2.6

1.5

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

320

1.71

2.54

2.0

1.6

1.90

1.57

mg/l

0.29

251

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

2.57

2.51

1.4

1.9

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

357

1.67

2.45

2.7

3.0

2.49

2.45

mmol/l

1.00

318

(3049717) Cytology report of Urine Cyto stain

2.29

2.39

1.9

3.1

—

(4195642) Thrombophilia screening test

6.38

2.38

1.4

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

6.38

2.38

1.2

1.4

103.80

116.13

—

(3007461) Platelets [#/volume] in Blood

162

1439

1.83

2.35

51.3

27.4

235.07

236.64

e9/l

0.11

156

1403

(3026361) Erythrocytes [#/volume] in Blood

162

1439

1.83

2.35

51.3

27.4

4.23

4.38

e12/l

2.88

154

1393

(3010813) Leukocytes [#/volume] in Blood

162

1439

1.83

2.35

51.6

27.4

7.08

6.77

e9/l

1.02

154

1392

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

158

1.90

2.33

5.7

3.8

—

(3019977) pH of Arterial blood

213

1.79

2.31

10.2

6.7

7.43

7.42

0.39

137

(4024509) Urine culture

0.00

2.29

0.0

2.0

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

729

1.54

2.24

2.3

2.1

86.55

96.14

pmol/l

1.15

382

(3021589) Normoblasts [#/volume] in Blood

589

1.55

2.22

23.9

12.3

0.00

0.01

e9/l

0.66

480

(40758558) Short blood count panel - Blood

410

1.60

2.20

7.6

6.1

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

257

1.70

2.19

4.1

3.0

0.43

1.14

e6/l

2.73

149

(3000012) Reticulocyte production index

2.87

2.17

1.5

2.1

1.08

0.83

—

(3044290) Cell count panel - Cerebral spinal fluid

3.29

2.12

1.3

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

5.10

2.08

1.2

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

3.59

2.07

1.3

1.9

—

(3016502) Oxygen saturation in Arterial blood

196

1.76

2.07

10.9

6.8

96.28

94.83

1.12

188

(40761511) CBC panel - Blood by Automated count

154

1364

1.67

2.06

34.8

16.4

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

4.09

2.05

1.2

2.0

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

3.83

1.95

1.2

1.9

—

(40761536) Microorganisms panel - Urine sediment

116

1.91

1.87

5.3

3.9

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

145

1277

1.56

1.87

5.9

6.8

41.28

40.06

mmol/mol

0.87

127

1163

(3004451) EKG impression Narrative

4.25

1.83

1.4

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

391

1.53

1.81

2.6

3.3

0.67

0.88

ug/l

1.27

269

(3021788) Differential panel - Synovial fluid

2.83

1.81

2.0

1.2

—

(40760892) CBC W Ordered Manual Differential panel - Blood

296

1.58

1.80

7.1

5.5

—

(3017181) Myelocytes/Leukocytes in Blood

141

1.80

1.78

7.2

3.8

0.23

0.95

2.74

(3021440) Promyelocytes/Leukocytes in Blood

134

1.81

1.76

7.4

3.9

0.00

0.17

1.72

(3044889) 12 lead EKG panel

115

974

1.45

1.73

6.6

4.6

—

0.40

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

3.92

1.72

1.2

1.3

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

175

1.70

12.1

7.4

123.39

120.85

g/l

0.24

170

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

148

1321

1.53

1.68

5.2

5.9

2.40

2.57

mmol/l

1.32

131

1178

(3024891) Influenza virus A+B Ag [Presence] in Specimen

2.65

1.68

1.3

1.2

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

2.65

1.68

1.5

1.6

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

3.23

1.67

2.2

1.3

—

(3042631) Mycobacterium sp identified in Specimen

2.87

1.66

2.0

2.6

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

147

1313

1.52

1.63

5.1

5.6

5.92

6.06

mmol/l

0.88

132

1162

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

139

1230

1.48

1.60

4.8

5.0

2.31

2.03

mu/l

1.23

121

1085

(3003327) Ova and parasites identified in Stool by Light microscopy

2.75

1.59

1.7

1.5

—

(40768793) Breast Pathology biopsy report

2.75

1.59

1.1

1.2

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

3.06

1.59

2.7

3.1

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

228

1.60

1.58

12.9

5.9

103.68

104.42

mmol/l

0.43

228

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

3.39

1.53

1.4

1.2

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

3.39

1.53

1.2

1.3

0.22

nmol/l

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

214

1.60

1.51

1.3

37.35

42.14

iu/ml

0.09

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

141

1.72

1.50

7.8

3.4

1.20

1.22

mmol/l

0.58

118

(3014007) Fractional oxyhemoglobin in Arterial blood

110

1.81

1.49

16.5

9.1

94.73

93.77

0.48

110

(3007566) Smooth muscle Ab [Titer] in Serum

2.56

1.46

1.6

1.3

—

114.00

—

(21494434) Karyotype in Bone marrow

2.78

1.44

1.0

1.1

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

2.78

1.44

6.0

4.5

—

(3025159) Blasts/Leukocytes in Blood

136

1.70

1.40

7.7

4.2

0.00

0.33

0.91

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

1.85

1.38

17.3

8.5

15.64

15.69

0.02

(3009261) Glucose [Presence] in Urine by Test strip

771

1.37

1.35

4.5

4.1

0.00

1.86

estimate

0.50

161

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

137

1227

1.41

1.33

4.5

4.3

1.27

1.22

mmol/l

0.35

120

1086

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

2.55

1.31

1.0

1.1

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

2.14

1.30

1.3

1.5

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

2.34

1.28

1.4

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

2.34

1.28

1.4

1.3

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

189

1.56

1.28

13.8

7.9

—

(36660697) Celiac disease serology panel - Serum

1.83

1.27

1.1

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

538

1.38

1.27

3.9

5.0

20.78

22.08

0.33

291

(3002256) Pathology report gross observation

208

1.52

1.22

1.2

1.4

—

(3002179) Metamyelocytes/Leukocytes in Blood

134

1.64

1.20

7.6

3.7

0.08

0.46

2.01

(40768795) Lymph node Pathology biopsy report

2.54

1.16

1.4

1.1

—

(3034770) Mitochondria Ab [Titer] in Serum

2.38

1.13

1.4

1.2

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

113

996

1.33

1.12

3.8

4.0

15.12

15.15

pmol/l

0.03

100

881

(3023419) Bacteria identified in Sputum by Culture

2.42

1.09

1.0

2.4

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

2.42

1.09

1.4

1.2

—

(3035933) Granulocytes/Leukocytes in Blood

2.23

1.09

4.9

2.7

59.29

60.12

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

141

1290

1.36

1.05

5.0

5.1

4.28

4.47

mmol/l

1.13

126

1165

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

2.10

1.04

1.1

1.5

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

1.96

1.03

1.3

1.5

—

(3035715) Granulocytes [#/volume] in Blood

2.20

0.98

6.0

2.6

5.53

4.60

e9/l

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

673

1.30

0.96

5.1

6.1

3.56

5.18

ug/l

0.44

581

(3005322) IgE [Units/volume] in Serum or Plasma

1.80

0.96

1.2

39.47

446.47

u/ml

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

1.93

0.95

1.9

1.3

—

(3025941) Bacteria identified in Stool by Culture

1.76

0.95

1.2

1.5

—

(3019060) Gas panel - Arterial blood

127

1.55

0.93

2.8

3.9

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

139

1281

1.31

0.90

4.9

5.0

1.39

1.46

mmol/l

1.03

123

1140

(3021601) Nitrite [Presence] in Urine by Test strip

757

1.27

0.88

4.5

4.0

0.00

estimate

-0.00

163

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

1.77

0.83

1.1

1.4

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

200

1.41

0.82

1.3

3.78

17.44

u/ml

1.07

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

354

1.32

0.81

1.6

2.0

488.13

433.69

pmol/l

0.58

285

(40768797) Stomach Pathology biopsy report

202

1.39

0.78

1.5

1.2

—

(3035350) Ketones [Presence] in Urine by Test strip

768

1.24

0.76

4.6

4.0

0.00

estimate

-0.00

169

(3048929) Epstein Barr virus Ab [Presence] in Serum

2.11

0.75

1.2

1.1

—

(3020891) Body temperature

1.59

0.74

2.8

4.1

37.01

36.91

°c

1.28

(1002224) Polysomnography panel

1.82

0.73

1.1

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

1.78

0.72

1.1

1.5

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

1.95

0.71

1.4

1.3

—

(3014051) Protein [Presence] in Urine by Test strip

353

1.28

0.68

3.7

3.1

—

0.00

—

(40768443) Skin Pathology biopsy report

1.61

0.66

1.1

1.3

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1.61

0.66

1.1

1.4

—

(3044941) Cell count panel - Synovial fluid

1.74

0.64

1.0

1.2

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

211

1.33

0.61

3.1

4.9

34.50

32.24

0.51

139

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

626

1.21

0.60

2.4

2.2

81.10

79.23

nmol/l

0.19

538

(3000492) Spirometry study

107

1.44

0.57

1.3

1.4

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

324

1.26

0.57

4.0

4.1

—

0.00

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1.64

0.56

1.2

1.4

—

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

137

1295

1.20

0.52

35.6

17.4

63.76

72.01

ml/min/173m2

3.55

126

1220

(3015736) pH of Urine

590

1.18

0.47

3.8

3.7

6.22

6.27

0.14

335

(3007930) Methemoglobin/Hemoglobin.total in Blood

1.42

0.41

4.4

3.6

0.79

0.97

0.95

(4094501) Cardiovascular stress test using bicycle ergometer

1.53

0.41

1.2

1.1

—

(3044242) Glucose [Moles/volume] in Arterial blood

0.00

0.41

0.0

1.5

—

8.75

—

(3019230) Fractional oxyhemoglobin in Venous blood

1.48

0.40

5.2

1.4

63.20

59.44

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

106

1.35

0.40

1.4

1.3

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

124

1.32

0.40

1.1

1.4

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

1.37

0.39

3.8

2.2

0.75

0.63

0.46

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

1.37

0.39

3.5

1.8

2.25

1.70

0.59

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

1.37

0.39

3.8

2.2

1.07

1.10

0.10

(3048689) Calprotectin [Mass/mass] in Stool

126

1.29

0.36

2.6

2.3

155.63

140.05

ug/g

0.12

105

(3003694) ABO and Rh group [Type] in Blood

351

1.18

0.36

1.3

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

1.39

0.35

1.1

1.3

—

(3041096) Erythrocytes [Presence] in Urine by Automated

419

1.16

0.35

5.0

3.6

0.09

0.22

estimate

0.26

122

(21494755) Public health laboratory ask at order entry panel

1.34

0.34

1.3

1.4

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

122

1.25

0.28

4.2

2.7

0.38

0.22

e6/l

0.49

116

(3019150) Specific gravity of Urine by Refractometry

339

0.86

0.26

4.3

4.5

1.01

1.02

kg/l

1.37

229

(3008152) Bicarbonate [Moles/volume] in Arterial blood

123

1.24

0.26

4.9

6.0

24.27

24.56

mmol/l

0.10

115

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

257

1.15

0.24

1.2

0.97

2.57

u/ml

—

(3018572) Chloride [Moles/volume] in Blood

1.36

0.23

2.8

4.6

104.00

104.94

mmol/l

—

(3039000) Anion gap in Blood by calculation

1.36

0.23

2.8

4.6

11.40

11.06

mmol/l

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

0.00

0.21

0.0

1.1

—

(40768441) Liver Pathology biopsy report

0.00

0.21

0.0

1.0

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

0.00

0.21

0.0

1.4

—

400.40

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

0.00

0.21

0.0

2.8

—

(44806420) Estimation of glomerular filtration rate

0.00

0.21

0.0

2.2

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

0.00

0.20

0.0

1.2

—

(3035637) Corticotropin [Mass/volume] in Plasma

0.00

0.20

0.0

1.4

—

46.47

—

(3047181) Lactate [Moles/volume] in Blood

1.21

0.20

2.7

4.9

1.25

mmol/l

—

(3017732) Neutrophils [#/volume] in Blood

159

1.15

0.15

2.4

2.8

3.87

5.80

e9/l

0.58

132

(3022145) Colonoscopy Study observation

161

1.13

0.13

1.2

1.3

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

108

0.83

0.13

2.0

1.4

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

1.11

0.10

2.8

1.1

—

(3020961) Endomysium IgA Ab [Titer] in Serum

1.09

0.09

1.0

1.1

—

(3029937) Albumin [Presence] in Urine by Test strip

461

1.06

0.08

4.9

4.2

0.05

0.00

estimate

0.48

141

(3000330) Specific gravity of Urine by Test strip

0.86

0.07

6.3

4.5

1.02

ratio

—

(3021960) Folate [Moles/volume] in Serum or Plasma

523

1.05

0.07

1.8

1.7

22.39

20.86

nmol/l

0.24

425

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

1.09

0.03

2.3

2.5

—

(1761868) Lipid panel - Serum or Plasma

408

0.98

0.01

2.8

3.3

—

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

116

1.04

0.00

1.9

1.4

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

589

1.00

0.00

5.0

4.2

0.08

0.01

estimate

0.36

137

(3032773) Endomysium IgG Ab [Titer] in Serum

0.00

0.0

1.0

—

(4015189) Microbial culture of sputum

0.00

0.0

1.9

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

126.25

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

0.00

-0.00

0.0

2.2

—

4.88

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

3.0

—

8.58

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

0.00

-0.00

0.0

1.0

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

0.00

-0.00

0.0

1.0

—

189.43

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

0.97

-0.00

1.1

1.3

—

50.30

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

0.00

-0.00

0.0

2.2

—

8.86

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

0.00

-0.00

0.0

1.0

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

0.00

-0.00

0.0

1.0

—

(3011544) Albumin [Mass/volume] in Pleural fluid

0.00

-0.00

0.0

1.0

—

16.52

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

0.00

-0.00

0.0

1.3

—

78.58

—

(3028707) Methadone [Presence] in Urine by Screen method

0.00

-0.00

0.0

1.4

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

0.00

-0.00

0.0

1.8

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.2

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

0.00

-0.00

0.0

1.2

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

0.00

-0.00

0.0

1.6

—

324.80

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

0.00

-0.00

0.0

1.8

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.3

—

96.03

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

0.00

-0.00

0.0

1.0

—

6.37

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

0.00

-0.00

0.0

1.1

—

Mortality – FinRegistry

↥

Association

Association between endpoint E4_AMYL_ORGAN and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have E4_AMYL_ORGAN.

N-year risk	Females	Males
1	No data	No data
5	No data	No data
10	No data	No data
15	No data	No data
20	No data	No data

Relationships between endpoints

↥

Index endpoint: E4_AMYL_ORGAN – Organ-limited amyloidosis

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Organ-limited amyloidosis

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

TimeCodeWAS

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints